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ABSTRACT 
 
 mRNA decay is an important step in gene regulation, environmental 
responsiveness, and mRNA quality control. One such quality control pathway, Nonsense-
mediated mRNA Decay (NMD), targets transcripts whose translation terminates 
prematurely. However, the scope and the defining features of NMD-targeted transcripts 
remain elusive. To address these issues, we re-evaluated the genome-wide expression 
of annotated transcripts in yeast cells harboring deletions of the UPF1, UPF2, or UPF3 
genes. The vast majority of NMD-regulated transcripts are normal-looking protein-coding 
mRNAs. Our bioinformatics analyses reveal that this set of NMD-regulated transcripts 
generally have lower translational efficiency, lower average codon optimality scores, and 
higher ratios of out-of-frame translation.  
 General mRNA decay is predominantly mediated by decapping by the Dcp1-Dcp2 
complex and 5' to 3' decay by Xrn1, but the exact mechanism of decapping regulation 
has remained largely unknown. Several in vitro and in vivo studies have revealed the 
importance of the C-terminal extension of Dcp2 and the identities of many decapping 
regulators that interact with the decapping complex. To better understand how decapping 
regulation is achieved by the C-terminal extension of Dcp2 we generated RNA-Seq 
libraries from a Dcp2 allele that lacks this portion of Dcp2 along with libraries from strains 
that contain single deletions of several decapping activators. Our transcriptome-wide 
results indicate that the C-terminal extension of Dcp2 is crucial for efficient regulation of 
decapping, and different decapping activators are responsible for targeting different sets 
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of mRNAs. Considering the limited pool of Dcp1-Dcp2 in the cell decapping activators 
might be in competition for decapping complex binding. 
 Collectively, our results yield valuable insights into the mechanism of substrate 
selection for mRNA quality control and decay in yeast. 
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mRNA DECAY IN SACCHAROMYCES CEREVISIAE 
 
OVERVIEW 
 All RNAs in the cell are subject to turnover as a part of their life cycles and 
differential degradation of mRNAs can play important roles in the regulation of cellular 
responses to external stimuli. Degradation of mRNAs in yeast occurs by two main 
mechanisms, both of which are initiated by shortening of the poly(A) tail, a process called 
deadenylation. Deadenylation in yeast is carried out by two complexes, the Pan2-Pan3 
complex and the Ccr4-Not complex (Wahle and Winkler, 2013). Following deadenylation, 
transcripts are either degraded by decapping by the Dcp1-Dcp2 enzyme (Dunckley and 
Parker, 1999), followed by 5' to 3' exonucleolytic decay by Xrn1 (Long and McNally, 
2003), or are subjected to 3' to 5' decay by the large exosome complex (Liu et al., 2006). 
Several lines of evidence suggest that, at least during exponential growth, yeast mRNAs 
are predominantly targeted by the 5’ to 3’ pathway. First, strains lacking components of 
the decapping enzyme grow very slowly, or mutations causing these defects are lethal in 
some strains (Beelman et al., 1996), but 3' to 5' decay mutants have significantly milder 
phenotypes (Anderson and Parker, 1998). Second, strains lacking proper 5' to 3' decay 
machinery show significant changes in both mRNA steady-state levels and decay rates 
(Beelman et al., 1996; He et al., 2003). Third, genome-wide mapping of mRNA decay 
intermediates show that only a handful of mRNAs are targeted by endonucleolytic 
cleavage (Harigaya and Parker, 2012).  
 Reports from different groups have shown that decay rates among mRNAs can 
vary significantly (Herrick et al., 1990; Presnyak et al., 2015; Sun et al., 2013). These 
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differences in decay rates can be the results of differential targeting of decapping, 
deadenylation, or exonucleolytic decay. Therefore, understanding how these processes 
are regulated, and the interplay between them, is crucial for elucidation of mRNA decay 
mechanisms.  
 In addition to normal turnover of mRNA, there are specialized mRNA decay 
pathways that monitor mRNA quality and translational fidelity. These pathways are No-
Go Decay (NGD) (Doma and Parker, 2006); Non-Stop Decay (NSD) (Frischmeyer et al., 
2002; van Hoof et al., 2002); and Nonsense-Mediated mRNA Decay (NMD) (Leeds et al., 
1991; Peltz et al., 1993; Pulak and Anderson, 1993). Targets of these pathways are 
subject to combinations of decapping, endonucleolytic cleavage, 5' to 3' decay, or 3' to 5' 
decay. While these processes are markedly different from regular mRNA turnover, they 
utilize the same decay machinery. Understanding how these pathways recognize their 
substrates can enhance our understanding of not only important aspects of mRNA quality 
control, but also normal mRNA turnover.  
 In this introduction, I summarize our current understanding of different decay 
mechanisms and the factors that are involved in these processes. The connections 
between different modes of decay and the complex interaction networks of their 
subsequent regulators illustrate how tightly mRNA decay is modulated and underscore 
the importance of mRNA turnover in gene expression.  
DEADENYLATION 
In eukaryotes, the processing and maturation of mRNAs includes the addition of a 
nontemplated 5’ 7-methylguanosine cap and a 3’ poly(A) tail. These modifications have 
profound effects on the entire life cycle of the mRNA. They are needed for efficient 
4 
 
translation of the mRNA and its protection from the decay machinery (Coller et al., 1998; 
Gray et al., 2000). Therefore, processes that target mRNAs for degradation also target 
the poly(A) tail.  
At steady-state, the size of the poly(A) tail of cytoplasmic mRNAs varies from <50 
nt in yeast to ~100 nt in mammalian cells (Subtelny et al., 2014). mRNAs with longer tails 
are thought to be translated more efficiently in vitro and in vivo and display higher 
ribosome densities in yeast (Beilharz and Preiss, 2007; Gallie, 1991; Munroe and 
Jacobson, 1990). This phenomenon has been attributed to the poly(A)-binding protein 
(Pab1 in yeast). The interaction network of Pab1 illustrates its central role in translation. 
Its interactions with eIF4G are thought to establish a closed loop mRNP (Amrani et al., 
2008; Gallie and Tanguay, 1994; Jacobson, 1996; Le et al., 2000), ensuring efficient 
translation initiation and possibly ribosome recycling for additional rounds of translation. 
Pab1 interactions with the eukaryotic release factor 3 (eRF3; Sup35 in yeast) (Kervestin 
et al., 2012; Roque et al., 2015) also appear to ensure efficient translation termination 
(Amrani et al., 2004; Kervestin et al., 2012) (see below)  
Consistent with the importance of the poly(A) tail, regulation of deadenylation - the 
removal of the poly(A) tail - is an important process in gene expression. There are two 
main deadenylases in the yeast cytoplasm: the Ccr4-Not complex and the Pan2-Pan3 
complex. These two complexes are thought to work cooperatively and regulate 
deadenylation in yeast.  
Ccr4-Not Complex 
The Ccr4-Not complex is the main deadenylase in all organisms studied (Wahle 
and Winkler, 2013). There are at least five canonical subunits in this complex: Ccr4, 
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Caf1/Pop2, Not1, Not2, and Not3/5 (Albert et al., 2000; Chen et al., 2001; Temme et al., 
2004). Ccr4 is one of the catalytic subunits of the complex (the other one being Caf1, see 
below). Its 3’ to 5’ exonuclease activity is Mg2+-dependent and poly(A) specific (Tucker et 
al., 2002; Tucker et al., 2001). Ccr4 belongs to the exonuclease-endonuclease-
phosphatase (EEP) class protein family (Dlakic, 2000). Structural studies (Basquin et al., 
2012; Bhaskar et al., 2013) show a heart-shaped protein with two β sheets and a central 
α-helix in the nuclease core of the protein. In addition to the nuclease domain, Ccr4 also 
contains an LLR repeat which is responsible for interactions with Caf1 (Dupressoir et al., 
2001; Malvar et al., 1992). Caf1 is the second catalytic subunit of the Ccr4-Not complex 
and is also universally conserved in eukaryotes (Schwede et al., 2008). Although 
Saccharomyces cerevisiae Caf1 lacks the catalytic residues that are thought to be 
important for activity, nuclease activity has been reported for the recombinant protein 
(Daugeron et al., 2001; Thore et al., 2003). Its sequence and the catalytic activity is 
consistent with the DEDD family of nucleases (Zuo and Deutscher, 2001). The name 
comes from four conserved amino acid residues that are necessary for coordinating Mg2+ 
cations for substrate hydrolysis (Andersen et al., 2009; Jonstrup et al., 2007). The large 
Not1 protein serves as the bridge for most of the interactions (Bai et al., 1999; Maillet and 
Collart, 2002; Maillet et al., 2000). Previously published reports present evidence 
suggesting that the Ccr4-Not complex exclusively exists as a single complex (Maillet et 
al., 2000; Russell et al., 2002; Temme et al., 2010) and both deadenylases are required 
for efficient poly(A) shortening in vitro (Maryati et al., 2015). The Ccr4-Not complex can 
degrade poly(A) tails processively, but its activity is inhibited by the poly(A)-binding 
protein (Cosson et al., 2002; Tucker et al., 2002). This illustrates the need for a 
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mechanism that would assist in removing the poly(A)-binding protein or shorten the 
poly(A) tail and thus reduce the affinity of Pab1. The Pan2-Pan3 complex fulfills this role 
in the cell.  
Pan2-Pan3 complex 
The poly(A)-specific nuclease (PAN) was the first deadenylating enzyme 
discovered (Sachs and Deardorff, 1992). This complex contains two subunits Pan2 and 
Pan3, Pan2 being the catalytic subunit (Boeck et al., 1996; Brown et al., 1996; Uchida et 
al., 2004). Pan2, like Caf1, belongs to the DEDD family of exonucleases and its activity 
depends on divalent cations (Brown et al., 1996; Zuo and Deutscher, 2001). In sharp 
contrast with Ccr4-Not complex, the activity of Pan2 is enhanced by the presence of 
poly(A)-binding protein and Pan3 (Lowell et al., 1992; Sachs and Deardorff, 1992; Schafer 
et al., 2014; Uchida et al., 2004). At least in vitro the Pan2 can deadenylate without 
poly(A)-binding protein, but not without Pan3 (Jonas et al., 2014; Schafer et al., 2014). 
The Pan2-Pan3 complex shows 1:2 stoichiometry and a distributive mechanism of action, 
with kinetic enhancement of Pan2 accomplished by interactions between Pan3 and Pab1 
(Simon and Seraphin, 2007; Wolf et al., 2014; Yao et al., 2007; Zhang et al., 2013). The 
role of the Pan complex is thought to be the trimming of the poly(A) tail (Lowell et al., 
1992; Yamashita et al., 2005) before the tail is completely degraded by the Ccr4-Not 
complex (Brown and Sachs, 1998; Petit et al., 2012; Temme et al., 2004; Tucker et al., 
2001). In pab1∆ cells, mRNAs have elongated tails, and kinetic analyses show a lag 
phase for deadenylation in the absence of Pab1 in vitro  (Caponigro and Parker, 1995; 
Sachs and Davis, 1989). 
 Targeting specific mRNAs for deadenylation 
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Some cellular proteins that bind to mRNAs in a sequence specific manner are 
implicated in the recruitment of deadenylation complexes. The six Puf proteins for 
example, bind to specific sequences and can regulate almost 10% of the transcriptome 
(Gerber et al., 2004; Olivas and Parker, 2000; Yosefzon et al., 2011). In yeast Puf1, Puf3, 
Puf4, and Puf5 have all been shown to promote poly(A) shortening on different subsets 
of mRNAs (Goldstrohm et al., 2007; Hook et al., 2007; Olivas and Parker, 2000; Tadauchi 
et al., 2001; Ulbricht and Olivas, 2008). At least one factor, Puf5, accomplishes this task 
by direct interactions with Caf1 (Goldstrohm et al., 2006; Goldstrohm et al., 2007). In 
addition, these proteins have been shown to inhibit translation to further contribute to 
deadenylation (Chritton and Wickens, 2011). Another example of sequence-dependent 
deadenylation involves the Vts1 protein, which recognizes a specific stem-loop sequence 
(Aviv et al., 2006) and recruits the Ccr4-Not complex (Rendl et al., 2008). Further, linking 
decapping and deadenylation, at least in mammalian cells Pat1 has been shown to 
interact with Not1 (Ozgur et al., 2010). Considering the importance of deadenylation in 
mRNA decay there are probably additional factors that either recognize mRNA 
sequences or regulate deadenylation rates based on environmental cues. Poly(A) 
shortening, however, is only one step in exonucleolytic decay of mRNAs in the cytoplasm. 
5' to 3' and 3' to 5' decay are responsible for complete degradation of mRNAs, usually 
after deadenylation (see below). 
5’ TO 3’ DECAY BY XRN1 
 There are two main 5’ to 3’ exoribonucleases in yeast, nuclear Xrn2/Rat1 and 
cytoplasmic Xrn1. Xrn2/Rat1 is involved in ribosomal RNA maturation, mRNA 
transcription termination, and telomere maintenance(Wang and Pestov, 2011). Xrn1 is is 
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responsible for the 5’ to 3’ decay of mRNAs after decapping or endonucleolytic cleavage 
(Orban and Izaurralde, 2005) (see below).  
 The well conserved Xrn1 protein contains several domains. N-terminal CR1 and 
CR2 sites are shared with Xrn2, with CR1 containing the catalytic activity and the less 
conserved CR2 enhancing the enzymatic activity of CR1 (Xiang et al., 2009). CR1 
contains seven well conserved acidic amino acids that are involved in coordinating a Mg2+ 
ion that is essential for activity. Xrn1 has additional domains that Xrn2 lacks. Its middle 
PAZ/Tudor, KOW, winged helix, and SH3-like domains are conserved from humans to 
yeast (Chang et al., 2011; Jinek et al., 2011). 
 Xrn1 degrades decapped mRNAs harboring a 5’ phosphate. The 5’ phosphate is 
recognized by a basic pocket in Xrn1 and the 5’ cap generates steric hindrance with this 
pocket, thus inhibiting its activity. This requirement for a 5' phosphate explains Xrn1's 
dependence on decapping for mRNA decay (see below). The tower domain degrades its 
substrates processively (Page et al., 1998). The PAZ/Tudor domain plays a structural role 
stabilizing the catalytic domain. The C-terminal domain structure of Xrn1 has not been 
elucidated, but deletion and mutagenesis analyses suggest that it is required for 
enzymatic activity (Page et al., 1998). The RNA channel of Xrn1 is large enough to 
accommodate single-stranded RNA. Xrn1 stalls when in contact with large stem-loops,  
although the enzyme can perform some unwinding of smaller structures (Bashkirov et al. 
1997)  (Bashkirov et al., 1997).  
 Interestingly, Xrn1 and the exosome (see below) do not co-localize in the cell 
despite reports showing at least partial redundancy in their activities (Bashkirov et al., 
1997). Consistent with its role in mRNA decay, Xrn1 does co-localize with many factors 
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that are important for mRNA decapping and decay, e.g., Dcp1-Dcp2 or the Lsm1-7 
complex (Braun et al., 2012; Jinek et al., 2011), and can interact with Dcp1 directly (Braun 
et al., 2012). There is strong evidence from the literature that at least for some mRNAs 
Xrn1 can also promote decay co-translationally (Hu et al., 2009; Pelechano et al., 2015).  
 While Xrn1 is responsible for degradation of mRNAs, these transcripts are not its 
only substrates. Xrn1-dependent untranslated transcripts (XUTs) (Wery et al., 2016), 
cryptic untranslated transcripts (CUTs) (Wery et al., 2016; Xu et al., 2009), and stable 
untranslated transcripts (SUTs) (Xu et al., 2009) have all been shown to be targeted by 
Xrn1. Some of these transcripts have been proposed to be targeted by the NMD pathway 
(Malabat et al., 2015; Wery et al., 2016), but the limited evidence for their translation 
makes this mode of decay less likely.  
3’ TO 5’ DECAY BY THE EXOSOME 
 While Xrn1 is responsible for 5’ to 3’ mRNA decay, the large exosome complex is 
responsible 3’ to 5’ decay. The eukaryotic exosome is composed of ten or eleven subunits 
(Liu et al., 2006), which can be categorized in two different groups depending on their 
structural and functional attributes. The first group is composed of nine proteins 
comprising the exosome core, and includes small proteins largely limited to RNA binding 
domains (Liu et al., 2016; Liu et al., 2006). The second group is composed of Dis3 and 
Rrp6, which associate with the core proteins and provide catalytic activity to the exosome 
(Dziembowski et al., 2007; Schneider et al., 2009).  
 The architecture of the exosome core is well established and is principally derived 
from structures of the human and yeast complexes (Liu et al., 2016; Liu et al., 2006). The 
nine subunits of the core are arranged in a two-layer ring. The bottom layer is called the 
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“hexamer” which is composed of Rrp41-46 and Mtr3 (Liu et al., 2016; Liu et al., 2006) and 
the top layer is called the cap which contains Rrp4, Rrp40, and Csl4 (Ramos et al., 2006). 
The cap subunits do not contact one another. Instead, they are associated with the 
hexamer. The cap proteins form a three-fold symmetry on top of a trimer of dimers (Liu 
et al., 2016; Liu et al., 2006).  
 The core complex does not have any enzymatic activity. Dis3 and Rrp6 proteins 
that associate with the core provide the decay activity to the exosome. Dis3 is an 
endoribonuclease and the 3’ to 5’ exoribonuclease (Lebreton et al., 2008; Schaeffer et 
al., 2009; Schneider et al., 2009). Dis3's substrates are RNAs with single stranded 3’ ends 
but Dis3 can unwind intramolecular secondary structures (Dziembowski et al., 2007; 
Lorentzen et al., 2008). Rrp6 on the other hand belong the to the DEDD family nucleases 
(Briggs et al., 1998) but unlike Dis3, Rrp6 is a distributive RNAase (Januszyk et al., 2011; 
Midtgaard et al., 2006). This protein is a part of the 11-subunit nuclear exosome complex 
and does not contribute to cytoplasmic decay.  
Even though the core complex does not have any catalytic activity, it is necessary 
for exosome function (Allmang et al., 1999; Dziembowski et al., 2007; Mitchell et al., 
1997). Binding to the core complex markedly reduces the decay rate of RNA by impairing 
RNA binding activity of the exonucleases (Wasmuth and Lima, 2012), this decrease in 
activity is necessary to prevent indiscriminate decay of mRNAs.  
In the context of mRNA decay in the cytoplasm, the activity of the exosome is 
regulated by the superkiller proteins (Ski) (Anderson and Parker, 1998). In yeast this 
complex is composed of DEVH family RNA helicase Ski2 and RNA binding proteins Ski3, 
Ski8 and Ski7. The Ski complex is evolutionarily conserved and has been shown to take 
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part in 3' to 5' decay in both yeast and metazoans (Araki et al., 2001; Synowsky and Heck, 
2008; van Hoof et al., 2000; Wang et al., 2005). Ski2, Ski3 and Ski8 mediate protein-
protein interactions (D'Andrea and Regan, 2003; Stirnimann et al., 2010) and Ski7 is 
responsible for linking the exosome to the Ski complex to modulate RNA decay. While 
the majority of RNA decay is done by Xrn1 in yeast cytoplasm, the substrates of NGD 
and NSD are degraded by the exosome (see below). Yet, there seems to be significant 
redundancy between the two decay mechanisms (Parker, 2012). The extent of this 
redundancy is not well understood and how each decay mechanism chooses its 
substrates is an area of active research.  
DECAPPING 
 During transcription, eukaryotic mRNAs acquire a 5’ 7-methyl-guanosine cap 
which significantly promotes translation (Mitchell et al., 2010) by its interaction with eIF4E. 
In addition, the mRNA cap protects the transcript from non-specific attack by 5’ to 3’ 
exonucleases (Stevens, 1978). The removal of the 5' mRNA cap by the decapping 
complex is, therefore, a critical step in decay regulation and this process is closely linked 
with translation (see below). Unlike some other regulatory steps, e.g., translational 
repression, decapping is usually an irreversible process that inhibits translation initiation 
and commits transcripts to decay (Arribas-Layton et al., 2013). The occurrence of 
cytoplasmic recapping (Schoenberg and Maquat, 2009) indicates that mRNA decapping 
can be reversible in some instances. 
  Dcp1-Dcp2 decapping enzyme 
 The best characterized decapping protein is Dcp2. This protein was originally 
identified in yeast (Dunckley and Parker, 1999; He and Jacobson, 1995; Peltz et al., 
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1994), but subsequent studies revealed homologs in all eukaryotic model organisms 
(Cohen et al., 2005; Iwasaki et al., 2007; Steiger et al., 2003; Wang et al., 2002). Purified 
Dcp2 has decapping activity in vitro for long RNA substrates, but cannot effectively 
hydrolyze unmethylated cap, free GTP, or short capped oligonucleotides (LaGrandeur 
and Parker, 1998). Dcp2 contains a Nudix domain (Dunckley and Parker, 1999; Wang et 
al., 2002), a structure found in enzymes that hydrolyze nucleoside diphosphates that are 
linked to other biological moieties (Bessman et al., 1996) through conserved glutamate 
residues that coordinate Mn2+ or Mg2+ ions (Piccirillo et al., 2003; Steiger et al., 2003). 
Sequence analysis shows that the N-terminal region of Dcp2 is highly conserved among 
eukaryotes while its C-terminal extension is divergent both in length and sequence 
(ranging from ~175 amino acids in humans to ~700 in yeast) (Wang et al., 2002). In 
addition to the Nudix domain, the conserved N-terminal region of Dcp2 contains a Box A 
motif which is responsible for Dcp1 interaction, and a Box B motif that regulates RNA 
binding (Lykke-Andersen, 2002; Piccirillo et al., 2003; She et al., 2006; van Dijk et al., 
2002). Structural studies revealed that substrates bind to the Dcp1-Dcp2 complex via a 
channel that places the cap structure within the Nudix domain while the rest of the RNA 
wraps along the Box B domain. Dcp2 requires its substrates to be at least 12nt long for 
efficient decapping (Mugridge et al., 2016; She et al., 2008).  
 An essential in vivo cofactor of Dcp2 is Dcp1. This protein was originally described 
as the catalytic subunit of the complex and yeast strains lacking Dcp1 are highly deficient 
in decapping (LaGrandeur and Parker, 1998). Dcp1 directly interacts with Dcp2 and 
decapping activity is enhanced several orders of magnitude in vitro by that interaction 
(Steiger et al., 2003). Unlike Dcp2, Dcp1 is a small protein that contains an EVH1 domain, 
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which is implicated in modulating protein-protein interactions (Ball et al., 2002; She et al., 
2004). In addition to this domain, Dcp1 contains a trimerization domain in metazoans 
(Tritschler et al., 2009b). Mutations in this domain have been shown to impair decapping 
activity in vivo (Tritschler et al., 2009b). In its interaction with Dcp2, at least in the crystal 
structure from Schizosaccharomyces pombe, Dcp1 does not utilize these conserved 
domains, but instead uses N-terminal sequences that are only found in yeast species 
(She et al., 2008). Dcp1 in yeast also lacks C-terminal extensions that are present in other 
eukaryotes, mainly the HLM domains. However, to make up for this, the yeast Dcp2 
protein contains additional HLM sequences, some of which bind to the decapping 
activators Edc3 and Scd6 (Fromm et al., 2012; Harigaya et al., 2010) (see below). The 
presence of multiple binding domains is thought to increase affinity by avidity effects 
(Jonas and Izaurralde, 2013). Mutational analyses of similar sequences from 
Saccharomyces cerevisiae and two-hybrid analyses are consistent with these 
hypotheses (He and Jacobson, 2015a; He et al., 2014).  
 Structural studies revealed different conformations of the Dcp1-Dcp2 complex 
(She et al., 2008). The open conformation resembles that of apo-Dcp2 (She et al., 2006) 
and assumes a dumbbell-like shape. The closed conformation, on the other hand, places 
the Dcp2 N-terminus in close proximity of the Nudix domain to form a compact structure. 
Biochemical data indicates that this closed conformation is a close approximation of the 
active Dcp1-Dcp2 complex (She et al., 2008). Other structural data suggest that the 
enhancement of Dcp2 activity in the presence of Dcp1 is due to stabilization of the active 
conformation (Valkov et al., 2016). Mutations in residues that block the formation of the 
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closed complex result in loss of Dcp1 stimulation of Dcp2 and loss of decapping. (She et 
al., 2008).  
 Decapping and decay regulation is multifaceted 
 The Dcp1-Dcp2 decapping complex is stimulated by additional proteins called 
decapping activators. These activators are characterized by a modular architecture 
consisting of globular domains connected by flexible unstructured regions. For many 
decapping regulators these globular domains are well conserved, but the unstructured 
regions vary considerably both in length and in sequence among eukaryotes, yet these 
motifs are implicated in regulating complex assembly by binding to other folded domains 
(Jonas and Izaurralde, 2013). The first proteins that were identified to regulate decapping 
were the Edc1 and Edc2 proteins (Dunckley et al., 2001). Structural studies have shown 
the interaction of Edc1 and Edc2 with Dcp1 is responsible for activation of decapping in 
vitro by interacting with Dcp1's EVH1 domain (Borja et al., 2011; Wurm et al., 2016). 
Interestingly, deletion of Edc1 or Edc2 does not impair in vivo decay rates of reporter 
mRNAs (Dunckley et al., 2001). Yet, they were later shown to bind RNAs directly to 
stimulate decapping (Schwartz et al., 2003). While there are no homologs of Edc1 and 
Edc2 in metazoans, Edc3 is well conserved among eukaryotes (Fromm et al., 2012). This 
protein directly interacts with Dcp2 in yeast and stimulates the decapping reaction in vitro 
(Harigaya et al., 2010; Nissan et al., 2010). However, deletion of EDC3 in yeast results in 
upregulation of only 2 transcripts (Dong et al., 2010), illustrating how tightly decapping 
can be regulated. 
 Another enhancer of decapping is Pat1. This protein was initially identified in a 
mutational screen for stimulators of decapping (Nissan et al., 2010; Tharun et al., 2000) 
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and was later found to interact directly with Dcp2 (He and Jacobson, 2015a). Pat1 and its 
orthologs in other organisms have been shown to associate with other decapping 
regulators (Haas et al., 2010; Ozgur et al., 2010; Tharun et al., 2000). One of these 
interacting partners is the Lsm1-7 complex. This interaction is mediated by Lsm2 and 
Lsm3 within the complex (Nissan et al., 2010; Sharif and Conti, 2013). In Saccharomyces 
cerevisiae, the Lsm1-7 heptameric ring associates with mRNAs that have undergone 
deadenylation (Parker and Song, 2004). Deletion of the LSM1 or PAT1 genes results in 
accumulation of deadenylated but capped mRNAs (Tharun et al., 2000). Recombinant 
Lsm1-7-Pat1 complex has an intrinsic preference for oligoadenylated mRNAs over 
polyadenylated and this affinity depends on the presence of Pat1 (Chowdhury et al., 2014; 
Chowdhury et al., 2012). Yeast strains lacking Pat1 are unable to effectively inhibit 
translation in response to glucose starvation and overexpression of Pat1 leads to general 
translation repression (Coller and Parker, 2005). In addition, Pat1 shows RNA-dependent 
associations with eIF4E and eIF4G, as well as Pab1 (Tharun and Parker, 2001). These 
observations suggest that an Lsm1-7-Pat1 complex can prime an mRNP for decapping 
through translational inhibition by releasing initiation factors either by direct interactions 
of by further stimulating deadenylation and disrupting the closed-loop complex (Kahvejian 
et al., 2005).  
 The DEAD box helicase Dhh1 is also implicated in the regulation of decapping. 
Again, first identified in budding yeast as a decapping activator, deletion of DHH1 results 
in the accumulation of capped mRNA decay intermediates (Coller et al., 2001; Fischer 
and Weis, 2002). Dhh1 can inhibit translation when tethered to specific mRNAs (Sweet 
et al., 2012) and is thought to decrease translation efficiency by slowing the movement of 
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ribosomes on the mRNAs or targeting mRNAs that are already translating ineffectively 
due to lower codon optimality (Radhakrishnan et al., 2016). Interestingly, Dhh1 can 
accomplish this even when its ATPase activity is abolished by mutations (Carroll et al., 
2011). Interaction studies have shown that the C-terminal domain of Dhh1 has binding 
sites for the Edc3 and Pat1 proteins which, therefore, can compete for Dhh1 binding 
(Sharif et al., 2013). These binding motifs on Dhh1 reside near the ATP-dependent RNA-
binding site. Consequently, the binding of Pat1 or Edc3 to this patch of positively charged 
residues interferes with Dhh1 binding to RNA (Sharif et al., 2013). However, the biological 
implications of such regulation or the importance of the ATPase activity of Dhh1 remain 
unknown.  
 Other proteins have also been implicated in decapping activation through 
translational inhibition. Scd6, for example, has been shown to interact with eIF4G directly 
and to inhibit the joining of the 43S complex (Nissan et al., 2010; Rajyaguru et al., 2012). 
Scd6 can also interact with the C-terminal extension of Dcp2 and modestly increase its 
activity in vitro, linking translation inhibition to decapping (Fromm et al., 2012). However, 
it is not yet clear how these proteins can select their substrates for decapping, whether 
they associate with the decapping complex simultaneously with other decapping 
activators or how regulation of different transcripts is achieved. Alternatively, decapping 
activation could occur after a series of ordered exchanges of factors that ultimately end 
with the recruitment of the decapping complex.  
 In the cytoplasm, the mRNA cap is usually bound by the eIF4F complex. Within 
this structure, eIF4E directly binds to the 5' cap. In turn, this binding is stimulated by eIF4G 
and can decrease decapping rates in vitro (Ramirez et al., 2002; Schwartz and Parker, 
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2000; Vilela et al., 2000). The interaction between eIF4G and poly(A)-binding protein, 
leading to formation of the closed-loop complex, can protect the mRNA from decapping 
and decay (Roy and Jacobson, 2013). Mutations in eIF4E or eIF4G which slow down 
translation initiation also lead to increases in decay rates in vivo (Schwartz and Parker, 
1999). It has been demonstrated that, at least in yeast, decapping is accelerated when 
the poly(A) tail has been shortened to about 12 nucleotides (Decker and Parker, 1993). 
This is approximately the minimal length required for Pab1 binding (Sachs et al., 1987). 
Further, pab1 mutations result in uncoupling of deadenylation from decapping (Caponigro 
and Parker, 1995; Morrissey et al., 1999). These results indicate that, in the absence of 
Pab1, the shortening of the poly(A) tail is no longer a requirement for decapping and 
underscore the importance of the interactions between the poly(A) tail and the 5' cap. 
Based on these observations, decapping activation likely involves remodeling of the 
mRNP to allow access to the cap structure for hydrolysis. Therefore, it is not surprising 
that some decapping enhancers are also implicated in translation repression. 
  For general mRNA turnover, decapping occurs after mRNAs have been 
deadenylated. This order of events ensures that functional mRNAs are not targeted for 
decay prematurely. However, how decapping and deadenylation are coordinated is poorly 
understood. Pat1 may play important roles in this transition due to its interactions with the 
Ccr4-Not complex (see above) (Haas et al., 2010; Ozgur et al., 2010) and Dcp2 along 
with other decapping activators (Bonnerot et al., 2000; Bouveret et al., 2000; Braun et al., 
2012; Fromont-Racine et al., 2000; Haas et al., 2010; Ozgur et al., 2010; Pilkington and 
Parker, 2008; Tharun et al., 2000; Tharun and Parker, 2001). Further, Pat1 can link 
decapping to 5' to 3' decay by Xrn1 (see above) (Bouveret et al., 2000; Nissan et al., 
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2010), but the specifics of these interactions and the order of events are not well 
understood. Nonetheless, the interaction between Xrn1 and the decapping complex, 
either with the help of Pat1 or directly (Braun et al., 2012), ensures that decay can 
immediately follow decapping. Interestingly, overexpression of Xrn1 inhibits decapping in 
a dominant negative manner in flies (Braun et al., 2012), suggesting that excess Xrn1 can 
inhibit the ordered assembly of decapping complexes, possibly by sequestration of 
necessary components. 
 Substrate selection for decapping 
 Decapping can be activated in a transcript specific manner. In NMD (see below), 
direct interactions of Upf1 with the C-terminal extension of Dcp2 can recruit the decapping 
complex to its substrates (He and Jacobson, 2001, 2015a; Lykke-Andersen, 2002). 
Similarly, the ribosomal protein Rps28 and the export factor Yra1 appear to recruit Edc3 
to their own mRNA/pre-mRNA to autoregulate their expression (Badis et al., 2004; Dong 
et al., 2010; Dong et al., 2007; He and Jacobson, 2015a; He et al., 2014; Kolesnikova et 
al., 2013). Further, the binding of Puf3 to the Cox17 mRNA enhances decapping of this 
mRNA following deadenylation (Olivas and Parker, 2000; Ulbricht and Olivas, 2008).  
The recently discovered inhibitory element in the Dcp2 protein provides another 
regulatory mechanism for decapping (He and Jacobson, 2015a). Removal of this 
sequence results in a constitutively active protein that shows an overall loss of substrate 
specificity as evidenced by the bypassing of the requirement for Edc3 in decay of YRA1 
pre-mRNA (He and Jacobson, 2015a). This regulatory element is hypothesized to prevent 
non-specific decapping of mRNAs, thus ensuring a tightly regulated mode for mRNA 
decay and gene expression.  
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 The potential structural switches of the Dcp1-Dcp2 complex are even more 
complicated when these interacting partners are considered. The C-terminal extension of 
budding yeast Dcp2 contains several overlapping binding sites for decapping activators 
(He and Jacobson, 2015a). Structural evidence indicates that these interactions can 
stabilize the active conformation of the Dcp1-Dcp2 complex and activate decapping 
(Charenton et al., 2016; Valkov et al., 2016). The complex and modular nature of the 
Dcp1-Dcp2 interacting factors suggests that there can be different decapping complexes 
and that these complexes can have different substrate specificities. By utilizing different 
combinations of regulators, Dcp2 can achieve a large repertoire of substrates with a 
limited number of regulators. Lack of conservation of the C-terminal regions of Dcp2 can 
also hint at the divergent needs for mRNA decay regulation from single-celled organisms 
to mammals. This model of several different mutually exclusive decapping complexes is 
also consistent with the notion that decay rates in the cytoplasm show a large range of 
values (Presnyak et al., 2015; Sun et al., 2013). The mode of mRNA decapping regulation 
for each mRNA likely depends on numerous factors that interact with the decapping 
proteins to help recruit them to specific mRNAs. Quality control pathways such as NMD, 
NGD, or NSD can also promote decapping that is independent of deadenylation and the 
recruitment of decay factors in these pathways shows many similarities and differences 
between general decapping (see below).  
NONSENSE-MEDIATED mRNA DECAY (NMD) 
 NMD is one of several translational quality control pathways that monitor mRNA 
translational activities (Celik et al., 2015; Lykke-Andersen and Bennett, 2014; Shoemaker 
and Green, 2012). As its name suggests, NMD targets mRNAs that contain a premature 
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termination (nonsense) codon within an open reading frame, although recent studies 
revealed additional NMD targets that do not contain a PTC (see below).. Initially 
discovered in yeast and nematodes (Leeds et al., 1991; Peltz et al., 1993; Pulak and 
Anderson, 1993), NMD is a well conserved pathway present in all eukaryotes examined 
(Kertesz et al., 2006; Schweingruber et al., 2013). This pathway was initially thought to 
protect the cell from the deleterious effects of truncated polypeptides (He et al., 1993; 
Pulak and Anderson, 1993) arising because mutations, transcriptional errors, splicing 
errors, or alternative splicing events gave rise to premature termination codons (PTCs). 
However, genome-wide studies have revealed that NMD substrates are much more 
numerous and diverse than initially thought (He et al., 2003). Therefore, in addition to 
being a quality control pathway, NMD also serves as a key post-transcriptional regulatory 
mechanism. NMD can regulate approximately 5-20% of a cell’s transcriptome, affecting 
many aspects of cell biology, from proliferation to neuronal activity (He et al., 2003; Lelivelt 
and Culbertson, 1999; Mendell et al., 2004; Metzstein and Krasnow, 2006; Ramani et al., 
2009; Rayson et al., 2012; Rehwinkel et al., 2005; Tani et al., 2012; Weischenfeldt et al., 
2012; Wittkopp et al., 2009). 
 Substrates of the NMD pathway 
 NMD targets both PTC-containing and normal-looking mRNAs in the cell. These 
targets can be classified into several categories. One typical category, as noted above, 
includes transcripts on which an elongating ribosome encounters a PTC. The PTCs can 
be generated by mutations (He et al., 2003), leaky scanning at the initiation codon (Welch 
and Jacobson, 1999), transcriptional errors, internal transcription start sites (Malabat et 
al., 2015), unspliced mRNAs, or alternative splicing events (Gehring et al., 2005; He et 
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al., 1993; Jaillon et al., 2008; Kawashima et al., 2014; Lareau et al., 2007; Ma et al., 2008; 
Ni et al., 2007; Weischenfeldt et al., 2012). A second category includes transcripts that 
do not code for proteins and are presumably being translated erroneously, e.g., long 
noncoding RNAs (Kurihara et al., 2009; Lykke-Andersen et al., 2014; Tani et al., 2013), 
transcripts of pseudogenes (He et al., 2003; McGlincy and Smith, 2008), or small RNAs 
derived from intergenic regions (Smith et al., 2014; Thompson and Parker, 2007). A third 
category encompasses transcripts that undergo programmed frameshifting, such as the 
mRNAs of transposable elements (He et al., 2003). In addition to these substrates, 
mRNAs with upstream open reading frames (uORFs) (Colombo et al., 2017; He et al., 
2003; Heyer and Moore, 2016; Ingolia et al., 2009; Nyiko et al., 2009; Rehwinkel et al., 
2005) or unusually long 3’ UTRs (Colombo et al., 2017; Kebaara and Atkin, 2009; Kertesz 
et al., 2006; Muhlrad and Parker, 1999a; Singh et al., 2008; Zaborske et al., 2013) can 
also be targeted by NMD, although not all mRNAs with such attributes are subjected to 
accelerated decay. uORF-containing mRNAs can regulate their levels in a context 
dependent manner. For example, CPA1 mRNA in yeast can be targeted by NMD upon 
certain physiological cues. The peptide encoded by the uORF of this mRNA can control 
ribosome stalling depending on the levels of available arginine in the cytoplasm and 
regulate CPA1 mRNA degradation by NMD (Gaba et al., 2005). On a similar note, not all 
mRNAs with long 3’ UTRs are targeted by NMD. Some of these mRNAs can contain 
protective sequence elements that block NMD activity to ensure full expression of these 
genes (Ge et al., 2016; Toma et al., 2015).  
 The largest category of NMD substrates is comprised of mRNAs that do not 
contain any of the aforementioned features, i.e., they appear to be “normal” mRNAs. How 
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and why these mRNAs are targeted by NMD has been an active area of research, but 
reports from different groups have led to conflicting results. The question of how NMD 
selects its substrates has, therefore, remained unanswered (see below).  
 NMD machinery 
 NMD is a translation dependent process that is thought to be initiated by a 
nonsense codon in the ribosomal A site during translation elongation (Amrani et al., 
2004). NMD identifies distinguishing features of premature termination and targets PTC-
containing mRNAs for rapid decay. This process requires the activity of the Upf proteins 
-the principal regulators of NMD- and other factors that monitor or modulate Upf activity 
or initiate degradation of the targeted mRNA. 
  Upf proteins 
 In all eukaryotes examined, the activity of the Upf1, Upf2, and Upf3 proteins have 
been shown to be essential for NMD (Cui et al., 1995; Gatfield et al., 2003; He et al., 
1997; He and Jacobson, 1995; Leeds et al., 1991; Lykke-Andersen et al., 2000; Nicholson 
et al., 2012; Nicholson et al., 2010; Perlick et al., 1996; Salas-Marco and Bedwell, 2004). 
These proteins are, therefore, well conserved. Upf1 and Upf2 are cytoplasmic proteins 
and Upf3 is thought to shuttle between the nucleus and the cytoplasm (Lykke-Andersen 
et al., 2000; Serin et al., 2001) though the importance of this shuttling to NMD is unclear. 
Because NMD seems to recognizes termination events that appear premature, the 
recognition of a nonsense codon by translation of an mRNA is crucial. Consistently, the 
core Upf proteins interact with each other, ribosomes, and many translation and mRNA 
decay factors (see below).  
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 Upf1, the only Upf protein with a defined enzymatic activity, is a superfamily I 
helicase. Upf1 contains two conserved domains: an N-terminal cysteine-histidine rich 
domain and a C-terminal ATPase-Helicase domain (Altamura et al., 1992) (Chakrabarti 
et al., 2011; Clerici et al., 2009; Koonin, 1992). Purified Upf1 has RNA-dependent ATPase 
and ATP-dependent helicase activities (Bhattacharya et al., 2000; Czaplinski et al., 1995) 
which are enhanced by addition of Upf2 and Upf3 (Chamieh et al., 2008; Fiorini et al., 
2013). The enzymatic activities of Upf1 are essential for NMD (Chamieh et al., 2008; 
Fiorini et al., 2012; Fiorini et al., 2013; Weng et al., 1996), i.e., mutations that abolish 
these activities also result in protection of NMD substrates from rapid decay. Further, Upf 
proteins that lack ATP hydrolysis activities cannot associate with ribosomes (Min et al., 
2013). While our understanding of the role of these properties is limited there is some 
indirect evidence hinting at a role in termination complex disassembly from the mRNA 
(Durand et al., 2016; Franks et al., 2010; Ghosh et al., 2010; Serdar et al., 2016). 
Considering that Upf1 is a helicase that can exert substantial mechanical force on RNA 
in a processsive manner. Yeast two-hybrid and other structural studies have shown that 
Upf1’s CH domain interacts with the C-terminal region of Upf2 (He et al., 1997), the 
ribosomal protein Rps26 (Min et al., 2013), and the decapping enzyme Dcp2 (He and 
Jacobson, 1995, 2001)(see above), and self-associates (He et al., 2013). Since these 
interactions cannot occur simultaneously due to overlapping binding sites they hint at a 
sequential array of interactions that are necessary for targeting NMD substrates for 
decay. Metazoan Upf1 proteins have additional conserved domains that are rich in serine 
and glutamine (Applequist et al., 1997; Perlick et al., 1996). These residues have been 
shown to be important in phosphorylation/de-phosphorylation cycles, as well as 
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interactions with other metazoan specific regulators that are necessary for NMD (Ohnishi 
et al., 2003; Yamashita et al., 2001). While there are a handful of reports showing Upf1 
and Upf2 phosphorylation in yeast the biological importance of these events in yeast has 
not been thoroughly investigated (de Pinto et al., 2004; Lasalde et al., 2014; Wang et al., 
2006).  
 Upf2 acts as a bridge between Upf1 and Upf3. The N-terminal region of Upf2 
contains three eIF4G-like (MIF4G) domains (Aravind and Koonin, 2000; Clerici et al., 
2014; Kadlec et al., 2004; Ponting, 2000). The most C-terminal of these interacts with 
Upf3’s middle RRM domain (He et al., 1997; Kadlec et al., 2004) and, in metazoans, with 
the C-terminal domain of Smg1 (see below). Binding of Upf2 to Upf1 switches Upf1 from 
its RNA binding to an RNA unwinding conformation, as evidenced by an increase in 
helicase and ATPase activities and reduced RNA affinity (Chakrabarti et al., 2011; 
Chamieh et al., 2008).  
 Upf3 is a smaller, highly alkaline protein. There is only one UPF3 gene in the 
Saccharomyces cerevisiae genome, but, in humans, there are two copies, respectively 
encoding Upf3a and Upf3b (Lykke-Andersen et al., 2014; Mendell et al., 2004). The two 
isoforms have different expression patterns and while their activities are somewhat 
redundant their respective abilities to trigger NMD are markedly different (Kunz et al., 
2006). The central RRM domain of both Upf3s interact with Upf2 (Lejeune et al., 2003; 
Serin et al., 2001) and its C-terminal domain interacts with the exon junction complex 
(EJC) in higher eukaryotes (Buchwald et al., 2010; Gehring et al., 2003). Recent 
experiments suggest that Upf3a also is a testes-specific NMD inhibitor (Shum et al., 
2016). 
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 Additional NMD regulators 
 Smg Proteins 
 In higher eukaryotes, there are additional factors that regulate the activities of the 
Upf proteins. Smg1, Smg8, and Smg9 form a protein kinase complex that is responsible 
for phosphorylating Upf1. Smg1 contains the enzymatic activity in the complex while 
Smg8 and Smg9 regulate its activity. This is considered to be the rate limiting step in 
NMD in metazoans (Grimson et al., 2004; Kashima et al., 2006; Yamashita et al., 2009; 
Yamashita et al., 2001). Upf1 contains numerous phosphorylation sites although none of 
these sites seem to play a significant individual role, but they may work together to 
regulate Upf1 activity (Durand et al., 2016). The phosphorylation of Upf1 by the Smg1 
kinase requires Upf2 and Upf3, as well as other components of the exon-junction complex 
(EJC) (Lykke-Andersen and Bennett, 2014) (see below). Structurally related Smg5, 
Smg6, and Smg7 proteins are important for the de-phosphorylation of Upf1 (Page et al., 
1999; Yamashita, 2013). These proteins all contain a 14-3-3  (Jonas et al., 2013) motif 
and bind to phosphorylated Upf1 (Chakrabarti et al., 2014; Fukuhara et al., 2005; Jonas 
et al., 2013; Ohnishi et al., 2003; Okada-Katsuhata et al., 2012). In addition, Smg5 and 
Smg6 contain PIN motifs which are related to those found in the RNase H family of 
proteins (Glavan et al., 2006). Consistent with this characteristic, Smg6 has 
endonucleolytic activity and cleaves mRNAs to mark them for decay (Boehm et al., 2014; 
Eberle et al., 2009; Huntzinger et al., 2008; Lykke-Andersen et al., 2014; Schmidt et al., 
2015). Smg5 and Smg7 then form a heterodimer and recruit the Ccr4-Not deadenylase 
to promote mRNA deadenylation (Loh et al., 2013; Unterholzner and Izaurralde, 2004), 
and decay. To continue the phosphorylation and de-phosphorylation cycle in other rounds 
26 
 
of NMD, Smg5 interacts with the protein phosphatase PP2A (Anders et al., 2003; Ohnishi 
et al., 2003; Okada-Katsuhata et al., 2012; Page et al., 1999) to induce de-
phosphorylation of Upf1.  
 Eukaryotic Release Factors 
 Recognition of an mRNA as a substrate for NMD is dependent on identification of 
a premature termination codon in the coding region of the mRNA. mRNAs, therefore, 
need to be translated and the ribosome must encounter a nonsense codon in its A site. 
Upf proteins have been shown to interact with the release factors, eRF1 and eRF3 
(Czaplinski et al., 1995; Kashima et al., 2006; Singh et al., 2008). These interactions are 
thought to recruit the Upf factors to the mRNA. However, the exact role and the order of 
events that lead to recruitment of Upf proteins to a prematurely terminating ribosome are 
unclear. Upf1’s interaction with eRF1 and eRF3 leads to the formation of the SURF 
complex (Smg1-Upf1-release-factor) in higher eukaryotes (Kashima et al., 2006). Yeast 
Upf2 and Upf3 both interact with eRF3 and may be in competition with eRF1 for an eRF3 
interaction domain (Wang et al., 2001). Upf1 binding to GST-eRF1 or GST-eRF3 
decreases its ATPase activity (Czaplinski et al., 1995), possibly leading to stabilization of 
an mRNA-Upf1 complex. Upon binding to Upf2 and Upf3, the stalled termination complex 
is resolved with re-activation of Upf1’s enzymatic activities (Chamieh et al., 2008). While 
there are no direct observations for this order of events, there is circumstantial evidence 
supporting this model (see below).  
 Exon Junction Complex 
 In higher eukaryotes pre-mRNA splicing results in deposition of a protein complex 
near the site of splice junctions (Le Hir et al., 2000). This complex, aptly named exon 
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junction complex (EJC), consists of four core proteins (eIF4A3, Y14, Magoh and MLN51) 
(Bono and Gehring, 2011), as well as other ancillary proteins. However, the EJC is not 
present at all splice junctions (Sauliere et al., 2012) and could be present in non-canonical 
complexes (Singh et al., 2012) or show heterogeneity in its composition (Hauer et al., 
2016). Nonetheless, the EJC has substantial roles determining the fates of mRNAs on 
which it resides. A role for the EJC in NMD is supported by several lines of evidence. 
First, Upf3 directly interacts with the EJC complex (Kim et al., 2001; Lykke-Andersen et 
al., 2000). Second, the presence of an EJC near a PTC, while not strictly required, greatly 
enhances the efficiency of NMD (Buhler et al., 2006; Singh et al., 2008). Third, artificially 
tethering EJC components near a termination codon can render those mRNAs 
susceptible to NMD (Gehring et al., 2005; Gehring et al., 2003; Lykke-Andersen et al., 
2001). However, these lines of evidence cannot fully substantiate a role for the EJC in 
NMD. Since translation is needed for NMD, and the presence of an EJC can enhance 
translation of an mRNA (Chazal et al., 2013; Ma et al., 2008; Nott et al., 2004), an indirect 
effect cannot be ruled out.  
 NMD and translation termination 
Even though both premature and normal termination events occur with a nonsense 
codon in the ribosome’s A site, there must be substantial differences between these 
events. Understanding the cause and the consequences of these differences between 
the two termination events is the key to understanding how NMD is activated.  
 Normal Translation Termination  
 Translation termination happens when a translating ribosome reaches the end of 
an open reading frame and its A site is occupied by a nonsense codon. This process 
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includes recognition of the nonsense codon and hydrolysis of the ester bond between the 
tRNA and the nascent amino acid chain. The standard genetic code has three nonsense 
codons (UAA, UAG, and UGA) and when these codons are in the A site they are 
recognized by eRF1, a class 1 release factor (Ivanova et al., 2007). eRF1 is also 
responsible for release of the nascent peptide. The two glycines in the GGQ motif of eRF1 
adopt a specific conformation that allows the placement of this motif in the ribosomal 
peptidyl transferase center, which in turn causes conformational changes in the rRNA 
and allows access to a water molecule, exposing the ester bond to attack (Jin et al., 2010; 
Korostelev et al., 2010; Laurberg et al., 2008; Song et al., 2000; Weixlbaumer et al., 
2008). 
 eRF1 has three conserved domains that are present in all eukaryotes: the N-
terminal (N), middle (M), and C-terminal (C) domains (Song et al., 2000). The M domain 
consists of a β sheet and four α helices that adopt a conformation that exposes the GGQ 
motif (Frolova et al., 1999; Ivanova et al., 2007). Domain N is responsible for stop codon 
recognition mainly via its TASNIKS and YxCxxxF motifs, where residues interact with 
different nucleotides of nonsense codons (Bertram et al., 2001; Brown et al., 2015; Cheng 
et al., 2009; des Georges et al., 2014; Frolova et al., 2002; Hatin et al., 2009; Kolosov et 
al., 2005; Lekomtsev et al., 2007; Pillay et al., 2016; Salas-Marco et al., 2006; Seit-Nebi 
et al., 2002) in conjunction with longer range structural interactions (Blanchet et al., 2014; 
Kryuchkova et al., 2013). Finally, the C domain of eRF1 is important for its interactions 
with eRF3. The solution structure of eRF1 shows an extended conformation which seems 
unsuitable to catalyze peptide hydrolysis and nonsense recognition simultaneously 
(Mantsyzov et al., 2010). This observation suggested that, at some point during 
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termination, eRF1 must undergo significant conformational changes to achieve its goal 
(Brown et al., 2015; Matheisl et al., 2015). The induction of such conformational changes 
is accomplished by eRF1’s interaction with its partner, eRF3. Consequently, unlike its 
bacterial counterparts, eRF1 alone is very inefficient in vitro (Alkalaeva et al., 2006).  
 eRF3 is a class II release factor (Kisselev and Buckingham, 2000), a ribosome 
dependent GTPase. Via its C-terminal domain, eRF3 can form a stable complex with 
eRF1 (Merkulova et al., 1999), which is further enhanced by eRF1’s M domain 
(Kononenko et al., 2008). eRF1 and 80S ribosomes are essential for stimulation of eRF3’s 
GTPase activity, although this stimulation can occur in the absence of peptide hydrolysis 
(Frolova et al., 1996). Like eRF3, the activity of eRF1 is also greatly enhanced by its 
interacting partner (Alkalaeva et al., 2006). Upon GTP hydrolysis by eRF3 the 
conformational changes cause eRF1’s M domain to rotate and point the GGQ motif to the 
ribosome peptidyl transferase center. eRF1, in accordance with its role, then assumes a 
tRNA like structure (Brown et al., 2015; Matheisl et al., 2015).  
 Following nascent peptide release, the ribosome, a tRNA in the P site, and at least 
eRF1 on the A site (Pisarev et al., 2010; Pisareva et al., 2007) is still associated with the 
mRNA. The release of these factors from the mRNA is crucial not only for re-utilization of 
ribosomes in other cycles of translation, but also for the remaining ribosomes on the same 
mRNA to finish their respective rounds of translation. The release of the 60S subunit from 
the mRNA following translation termination is accomplished by the essential ABC 
cassette ATPase ABCE1 (Rli1 in yeast) (Pisarev et al., 2010). ABCE1's Walker A and 
Walker B domains are important for ATPase activity, Fe-S domain mediates interactions 
with eRF1 C-terminal domain (Brown et al., 2015; Kiosze-Becker et al., 2016; Preis et al., 
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2014). ABCE1 can only release the 60S subunit from the mRNA if it is preceded by eRF1 
binding, but not by puromycin induced release, indicating the importance of sequential 
assembly (Pisareva et al., 2011). Similarly, ABCE1 and eRF3 bind to the same domain 
on eRF1, and eRF1’s stimulation of ABCE1 activity is muted in the presence of eRF3 
(Shoemaker and Green, 2011). The activity of ABCE1 relies on Mg2+ ions yet high 
concentrations of Mg2+ can also inhibit this reaction (Sims and Igarashi, 2012). Consistent 
with its role in ribosome release, depletion of ABCE1 in yeast results in significant 
nonsense codon readthrough, even at normal termination codons (Young et al., 2015).  
 After the release of the 60S subunit the mRNA is still associated with the 40S and 
a tRNA. The removal of these factors is accomplished by the concerted efforts of eIF3, 
eIF1, eIF1A, and the non-essential subunit eIF3j (Pisarev et al., 2007; Pisarev et al., 
2010). eIF3 is a large complex that binds to the solvent exposed side of the ribosome 
(Siridechadilok et al., 2005), and eIF1 and eIF1A bind to the intersubunit side of the small 
ribosomal subunit (Kolupaeva et al., 2003; Rabl et al., 2011). Interactions of the 40S 
subunit with eIF1 and 1A induce conformational changes which result in opening of the 
mRNA channel and probably the release of the mRNA (Passmore et al., 2007). In 
addition, the binding on eIF3j involves interactions with the mRNA channel near the A site 
and this binding is thought to show negative cooperativity with the mRNA, further reducing 
the affinity of 40S for the mRNA (Fraser et al., 2007). While eIF1, eIF1A and eIF3j can 
completely dissociate in vitro assembled termination complexes, activities of the rest of 
eIF3 are crucial in vivo (Pisarev et al., 2007; Rodnina, 2010).  
 Premature termination is different from normal termination 
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 Although both normal and premature termination events begin when a nonsense 
codon occupies the ribosomal A site, the two events show considerable differences. In 
addition to the fact that most normal termination events do not trigger NMD, two other 
lines of evidence support this hypothesis. First, toeprint analyses in yeast cell-free 
extracts fail to show any signal from ribosomes positioned at a normal termination codon 
unless translation termination is rendered inefficient by a temperature-sensitive mutation 
in the gene encoding eRF1 (Amrani et al., 2004). In contrast, premature termination 
events readily yield toeprints in the same assay without any release factor inactivation 
(Amrani et al., 2004). This observation has been corroborated by similar results in 
mammalian cell-free systems using the β-globin mRNA (Peixeiro et al., 2012). Second, 
nonsense readthrough can occur at a much higher frequency at premature termination 
codons than at normal termination codons (Johansson and Jacobson, 2010; Kvas et al., 
2012; Maderazo et al., 2000; Roy et al., 2015; Wang et al., 2001).  
 Consistent with the notion that Upf proteins play important roles at premature 
termination events deletion of any one of these proteins results in increased readthrough 
at a PTC (Johansson and Jacobson, 2010; Kvas et al., 2012; Maderazo et al., 2000; Roy 
et al., 2015; Wang et al., 2001). However, these observations can, in part, be attributed 
to increased intracellular Mg2+ concentrations due to increased stability of the mRNAs for 
the uORF-containing Mg2+ transporters, Alr1 and Alr2 (Johansson and Jacobson, 2010). 
Adding another layer of complexity to the issue, the efficacy of ribosome recycling is 
dependent on Mg2+ levels, as ABCE1 activity is hindered in high Mg2+ concentrations 
(Sims and Igarashi, 2012) (see above). It is, therefore, possible that these effects are due 
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to decreased effects of the ABCE1 ATPase. However, there is currently no evidence 
linking ABCE1 to ribosome recycling at premature termination events.  
 Further evidence suggesting that premature termination is markedly different from 
normal termination is that ribosome re-utilization after premature termination is reduced 
in vivo and in vitro upon deletion of any of the Upf proteins (Amrani et al., 2004; Ghosh et 
al., 2010), suggesting that these termination events lack efficient ribosome recycling 
mechanisms in the absence of Upf proteins. Similarly, ATPase- or helicase-deficient Upf1 
leads to accumulation of decay intermediates that are blocked in subsequent steps in 
mRNA decay after being targeted by NMD (Serdar et al., 2016) (see below). These 
observations suggest that, similar to the NSD or NGD pathways, one role of the Upf 
proteins is to dissociate otherwise poorly dissociable mRNP complexes (Ghosh et al., 
2010) .  
 Different models for NMD targeting 
 Despite decades of research, our understanding of how NMD is activated remains 
incomplete. Published work from many groups has converged on three separate models 
of NMD activation. While there are common elements in each model they are 
fundamentally different in their view of how NMD selects its substrates.  
 Exon junction complex model 
 While this model does not apply to budding yeast, the inspiration for this hypothesis 
originates from observations that the degradation of nonsense-containing PGK1 mRNA 
requires both a downstream element and a trans-activating factor (Hrp1) that recognizes 
this sequence (Gonzalez et al., 2000). Several observations made in mammalian cells 
led to the development of a related model. First, almost all mammalian genes contain 
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introns and these are marked by EJCs after pre-mRNA splicing (Le Hir et al., 2000) and 
the normal stop codons for most mRNAs in higher eukaryotes are located in the last exon, 
meaning that there is no EJC after the annotated termination event (Nagy and Maquat, 
1998; Zhang et al., 1998). Second, the EJC travels with the mRNA to its location for 
translation and is removed during the first round of translation by the translation 
machinery-associated protein, Pym (Gehring et al., 2009). Finally, the EJC’s association 
with Upf3 directly connects this complex to NMD (Kim et al., 2001; Lykke-Andersen et al., 
2001). These and other observations led to the conclusion that, during the first round of 
translation, if a terminating ribosome is within close proximity of an EJC, that mRNA will 
be targeted for NMD. Following recognition of a PTC it is hypothesized that Upf1 is 
recruited to the mRNA and then later activated by Upf2 and Upf3, followed by mRNA 
decay (see below).  
 While intriguing, there is experimental evidence that contradicts the EJC model. 
For example, mRNAs can still be targeted by NMD in the absence of any introns (Rajavel 
and Neufeld, 2001; Singh et al., 2008). Recent reports suggested that the EJC itself is 
more heterogeneous than previously anticipated and not all exon junctions contain this 
complex (Singh et al., 2012). Further, an implication of the pioneer round of translation 
model is that only mRNAs that are bound to the cap binding protein, CBP, can be targeted 
for NMD, yet there is ample evidence suggesting that eIF4E bound mRNAs can be 
substrates of NMD (Durand and Lykke-Andersen, 2013; Rufener and Muhlemann, 2013).  
Finally, these results are in direct contrast with observations in yeast that NMD can target 
mRNAs at any time as evidenced by the rapid decay of hundreds of NMD substrates in a 
strain with GAL-regulated NMD (Johansson et al., 2007; Maderazo et al., 2003).  
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 Upf1 3’-UTR length sensing model 
 Premature termination would result in a long 3’-UTR, and some WT mRNAs with 
unusually long UTRs are also targets for NMD. Studies investigating the consequences 
of a long 3’-UTR suggested that Upf1 preferentially associates with these UTRs without 
any regard for translation or sequence (Hogg and Goff, 2010). However, this association 
could be disrupted by translating ribosomes. These observations, in conjunction with 
CLIP-Seq experiments (Gregersen et al., 2014; Hurt et al., 2013; Kurosaki et al., 2014; 
Zund et al., 2013; Zund and Muhlemann, 2013), led to the model that Upf1 can non-
specifically associate with mRNAs and that the extent of Upf1 occupancy of an mRNA 
can be a signal for NMD activation (Zund and Muhlemann, 2013). However, this model 
fails to account for several other observations. At least in yeast the protein levels of Upf1 
are not sufficient to have several molecules of Upf1 per mRNA (Ghaemmaghami et al., 
2003). Most importantly, translation independent association of Upf1 with mRNAs directly 
contradicts many observations indicating the essentiality of translation for NMD (Atkin et 
al., 1995; Atkin et al., 1997; Hu et al., 2010; Smith et al., 2014; Zhang et al., 1997). 
 faux-UTR model 
 First conceived to explain NMD in yeast (Amrani et al., 2004), the principal 
components of this model are supported by many observations from other model 
organisms (Behm-Ansmant et al., 2007a; Kertesz et al., 2006; Singh et al., 2008). This 
model suggests that factors present at a normal 3’-UTR, or at the poly(A) tail of an mRNA, 
are responsible for proper translation termination and the absence of these features or 
factors at a PTC is what distinguishes a premature termination event from a normal one. 
The main lines of evidence that support this model are: 1) The efficiency of NMD targeting 
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is inversely correlated to how close the premature termination is to the normal termination 
codon (Gatfield et al., 2003); 2) Artificial extensions of a 3’-UTR can target that mRNA for 
NMD (Muhlrad and Parker, 1999a); 3) Tethering of the poly(A)-binding protein or eRF3 
can inhibit targeting of mRNAs by NMD (Amrani et al., 2004; Behm-Ansmant et al., 2007a; 
Eberle et al., 2008; Ivanov et al., 2008; Kervestin et al., 2012; Silva et al., 2008); and 4) 
As mentioned above, premature termination or ribosome recycling are inefficient 
compared to their normal counterparts (Amrani et al., 2004).  
 The faux-UTR model can explain much of the evidence gathered from studies that 
used reporter systems for studying NMD. All the experimental constructs in these studies 
contained PTCs so they could be targeted by NMD. Yet, genome-wide studies in yeast 
(He et al., 2003) suggested that the largest subset of endogenous substrates of NMD 
includes mRNAs that do not contain a PTC in their open reading frames so the 
mechanism for targeting these mRNAs cannot be explained by any of the NMD activation 
models. 
 Mechanism of NMD targeted mRNA decay 
 Regardless of the mode of Upf1 targeting, NMD substrates are degraded by 
multiple mechanisms. In yeast, these mRNAs are degraded by decapping by the 
Dcp1/Dcp2 complex, followed by 5’ to 3’ decay by the Xrn1 exonuclease (He and 
Jacobson, 2001; Muhlrad and Parker, 1994) (see above). The decapping complex is 
thought be recruited to the mRNP by direct interaction with Upf1 (He and Jacobson, 1995, 
2015a). NMD targeted mRNAs can also be subjected to deadenylation followed by 3’ to 
5’ decay by the exosome, although this method seems to be preferred only in the absence 
of an active 5' to 3' decay pathway (Mitchell and Tollervey, 2003; Takahashi et al., 2003). 
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In higher eukaryotes, decay events are preceded by endonucleolytic cleavage by the 
Smg6 protein which cleaves the mRNA near the prematurely terminating ribosome, 
leading to degradation of each fragment by Xrn1 or the exosome (Boehm et al., 2014; 
Eberle et al., 2009; Huntzinger et al., 2008).  
 Work over the last two and half decades has shed light into many aspects of NMD, 
such as the identities of the core regulators and their interacting partners, the biochemical 
properties of many of the proteins involved in this pathway, and the many endogenous 
substrates of NMD. The inherent link between translation termination and NMD is 
supported by many lines of evidence from all model organisms studied. However, the 
exact mechanism of Upf recruitment to NMD targets and why some of the endogenous 
NMD substrates are targeted by NMD is still unclear. Because NMD requires translation 
termination, the last and non-rate-limiting step of a long and intricate biological process, 
understanding the differences between normal and premature translation termination and 
the mode of NMD activation has been challenging. Future work considering translation 
termination dynamics and the potentially ordered assembly of translation termination and 
Upf factors can shed light into this important quality control pathway.  
NON-STOP AND NO-GO DECAY 
 NMD is not the only mRNA quality control mechanism that monitors translation in 
the cell. Non-Stop Decay (NSD) (Frischmeyer et al., 2002; van Hoof et al., 2002) targets 
mRNAs that do not contain stop codons and, therefore, have ribosomes that have 
translated into the poly(A) tail of the mRNA. Conversely, No-Go Decay (NGD) (Doma and 
Parker, 2006) targets mRNAs on which ribosomes are stalled due to secondary structure 
and to a lesser extent long stretches of non-optimal codons. While the substrates of these 
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two pathways seem very different from one another they are recognized by the same 
factors.  
 Non-Stop Decay (NSD) 
 Initially discovered in yeast (Frischmeyer et al., 2002; van Hoof et al., 2002) NSD 
is a conserved mRNA quality control pathway that targets mRNAs that do not harbor a 
stop codon and, therefore, elongating ribosomes reach the poly(A) tail. The 
consequences of translating the poly(A) tail are twofold. First, this results in synthesis of 
a highly basic poly-lysine polypeptide which is targeted for degradation by the proteasome 
(Ito-Harashima et al., 2007; Wilson et al., 2007). Second, the translating ribosome is 
stalled at the end of the mRNA with an empty A site, which is resolved by the interacting 
partners, Dom34 and Hbs1 (Pisareva et al., 2011; Shoemaker et al., 2010) (see below), 
(Shoemaker et al., 2010).  
After being selected for decay, the mRNA is initially targeted for endonucleolytic 
cleavage (Tsuboi et al., 2012) followed by exosome mediated decay (Frischmeyer et al., 
2002; Inada and Aiba, 2005; Wilson et al., 2007). Like NMD, translation of transcripts is 
required for detection of NSD substrates and therefore these mRNAs are associated with 
polysomes (Guydosh and Green, 2014, 2017; Tsuboi et al., 2012) and inhibition of 
translation with cycloheximide inhibits NSD (Inada and Aiba, 2005).  
Consistent with the translation of the poly(A) tail these substrates do not have Pab1 
associated with their poly(A) tails (Inada and Aiba, 2005),  although it is unclear whether 
the ribosome is responsible for the removal of the poly(A)-binding protein from the mRNA. 
It is possible that the absence of Pab1 can play an important role in further destabilizing 
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these transcripts by disrupting the closed-loop complex and repressing translation (see 
above).  
 No-Go Decay (NGD) 
Another mRNA quality control pathway that utilizes the Dom34-Hbs1 pair is the 
NGD pathway. Again, first discovered in yeast (Doma and Parker, 2006), this pathway is 
also well conserved from archaea to mammals. Targets of NGD include mRNAs with 
substantial secondary structures (Doma and Parker, 2006) and to a lesser extent mRNAs 
with long stretches of non-optimal codons (Chen et al., 2010). 
Like NSD, the substrates of this pathway undergo endonucleolytic cleavage (Doma 
and Parker, 2006), but the identity of the endonuclease that performs this reaction 
remains unknown. The targets of NGD are cleaved just 5’ of a ribosome stall site (Chen 
et al., 2010). Following cleavage and ribosome dissociation by Dom34, Hbs1, and ABCE1 
ATPase (Pisareva et al., 2011; Shoemaker et al., 2010) (see below), the 5’ fragment is 
subjected to 3’ to 5’ decay by the exosome and the 3’ fragment is degraded 5’ to 3’ by 
Xrn1 (Doma and Parker, 2006). As expected, translation of the mRNA is required for 
detection of NGD substrates. Therefore, introduction of stem-loops into the 5’-UTR of 
mRNAs does not result in NGD targeting (Doma and Parker 2006).  
 Dom34 and Hbs1  
While the substrates of NSD and NGD seem very different, one common feature 
of these transcripts is that they are typified by stalled ribosomes. Considering that NSD 
substrates have an empty A site and NGD substrates can have any codon in the A site, 
a codon-independent mechanism to release these stalled complexes is needed. 
Consequently, the conserved proteins Dom34 (Pelota in higher eukaryotes) and Hbs1 
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have evolved to address this issue. Consistent with its function in releasing stalled 
ribosomes, the structure and activity of the Dom34-Hbs1 complex closely resembles that 
of eRF1-eRF3 (see above) (Becker et al., 2011; Chen et al., 2010; Graille et al., 2008) 
with some important distinctions. Unlike eRF1, Dom34 does not contain a GGQ motif 
(Chen et al., 2010); therefore, Dom34-Hbs1-GTP complex cannot perform peptide 
hydrolysis (Pisareva et al., 2011; Shoemaker et al., 2010). Nonetheless, GTP hydrolysis 
by Hbs1 induces similar conformational changes in Dom34. Followed by these changes, 
binding and ATP hydrolysis by the ABCE1 ATPase promotes 60S dissociation (Pisareva 
et al., 2011) and promotes ribosome recycling.  
NGD and NSD are not the only responsibilities of Dom34. This protein is also 
implicated in the re-activation of translation after glucose starvation (van den Elzen et al., 
2014). dom34∆ strains show subtle polysome defects compared to WT suggesting a 
general rescue mechanism for stalled ribosomes (van den Elzen et al., 2014). In line with 
this hypothesis, Dom34 has been implicated in releasing ribosomes that are stuck in 3’-
UTRs of mRNAs (Guydosh and Green, 2014, 2017).  
CONCLUSIONS 
 There are several avenues of research in the study of mRNA decay in yeast. While 
we have a thorough understanding of the factors involved in many of the decay 
processes, our understanding of how these pathways interact is still poorly understood. 
For example, the mechanism of substrate selection by the decapping complex and its 
interacting partners is still an open question. How the Xrn1 exonuclease is recruited to 
specific decay complexes or the preference for 5' to 3' as opposed to 3' to 5' decay in 
regular mRNA decay remains to be determined. An in vitro system where mRNA 
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translation coupled with decay could provide valuable insights into how substrates for 
each decay mechanism is selected. Elucidation of a more complete interaction network 
of decapping activators and the decapping complex will also provide a better 
understanding of step-wise recruitment of decay factors and potentially mutually exclusive 
complexes that target different mRNPs for decapping. Of course, the underlying 
implication is that different decay pathways regulate different aspects of the cellular 
machinery and that there is a direct relationship between turnover and function. Similarly, 
the order of assembly of Upf proteins in NMD and how these factors recruit decapping 
and decay factors remains to be resolved and an in vitro system where Upf targeting and 
decay can be closely monitored can shed light into the mechanism of substrate selection 
by NMD. 
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SUMMARY 
Nonsense-mediated mRNA decay (NMD) plays an important role in eukaryotic 
gene expression yet the scope and the defining features of NMD-targeted transcripts 
remain elusive. To address these issues, we re-evaluated the genome-wide expression 
of annotated transcripts in yeast cells harboring deletions of the UPF1, UPF2, or UPF3 
genes. Our new RNA-Seq analyses confirm previous results of studies, but also uncover 
hundreds of new NMD-regulated transcripts that had escaped previous detection, 
including many intron-containing pre-mRNAs and several non-coding RNAs. The vast 
majority of NMD-regulated transcripts are normal-looking protein-coding mRNAs. Our 
bioinformatics analyses reveal that this set of NMD-regulated transcripts generally have 
lower translational efficiency and higher ratios of out-of-frame translation. NMD-regulated 
transcripts also have lower average codon optimality scores and higher transition 
probability to non-optimal codons. Collectively, our results generate a comprehensive 
catalog of yeast NMD substrates and yield new insights into the mechanisms by which 
these transcripts are targeted by NMD.  
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INTRODUCTION 
Nonsense-mediated mRNA decay (NMD) is a eukaryotic surveillance mechanism 
that targets mRNAs undergoing premature translation termination for rapid degradation 
(He and Jacobson, 2015b; Kervestin and Jacobson, 2012; Lykke-Andersen and Bennett, 
2014). The pathway was initially uncovered in Saccharomyces cerevisiae and 
Caenorhabditis elegans (Leeds et al., 1991; Peltz et al., 1993; Pulak and Anderson, 1993) 
and later shown to be conserved from yeast to humans (Behm-Ansmant et al., 2007b; 
Schoenberg and Maquat, 2012). NMD’s function was originally thought to be limited to 
quality control, i.e., the elimination of mRNAs derived from genes harboring nonsense 
mutations to prevent the accumulation of potentially deleterious truncated polypeptides 
(He et al., 1993; Pulak and Anderson, 1993). However, NMD also targets a significant 
fraction of apparently normal and physiologically functional wild-type mRNAs 
(Schweingruber et al., 2013), indicating that it also serves as a fundamental post-
transcriptional regulatory mechanism for eukaryotic gene expression. Consistent with 
these important roles, NMD function is linked to diverse cellular processes, including cell 
growth and proliferation (Avery et al., 2011; Lou et al., 2014; Weischenfeldt et al., 2008), 
development and differentiation (Gong et al., 2009; Medghalchi et al., 2001; Metzstein 
and Krasnow, 2006; Wittkopp et al., 2009), innate immunity (Gloggnitzer et al., 2014), 
antiviral or stress responses (Balistreri et al., 2014; Sakaki et al., 2012), and neuronal 
activity or behavior (Colak et al., 2013; Giorgi et al., 2007).  
In all organisms examined the activation of NMD requires a set of conserved core 
regulatory factors, Upf1, Upf2, and Upf3 (He and Jacobson, 2015b; Kervestin and 
Jacobson, 2012). These three proteins interact with each other, the ribosome, and 
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multiple translation and mRNA decay factors (Kervestin and Jacobson, 2012). Based on 
these molecular interactions, several potential functions have been proposed for the Upf 
factors, including remodeling terminating mRNPs (Franks et al., 2010), releasing and 
recycling ribosomal subunits (Ghosh et al., 2010), and recruiting mRNA decay factors (He 
and Jacobson, 2015a; Nicholson et al., 2014; Okada-Katsuhata et al., 2012). However, 
the exact roles for the Upfs, and their modes of action in NMD, remain largely unknown.  
Despite the conservation of the core Upf proteins, NMD-targeted mRNAs appear 
to be degraded by different mechanisms in different eukaryotic cells. In yeast, NMD-
targeted mRNAs are degraded predominantly through a deadenylation-independent 
mechanism involving decapping by the Dcp1/Dcp2 decapping enzyme and 5’ to 3’ 
exonucleolytic digestion by Xrn1 (He and Jacobson, 2001; Muhlrad and Parker, 1994). In 
human cells, NMD-targeted mRNAs are degraded through multiple mechanisms 
including endonucleolytic cleavage (Eberle et al., 2009; Huntzinger et al., 2008; Lykke-
Andersen et al., 2014), deadenylation-dependent decapping (Loh et al., 2013; 
Unterholzner and Izaurralde, 2004; Yamashita et al., 2005), and exosome-mediated 3’ to 
5’ decay (Lejeune et al., 2003), with endonucleolytic decay appearing to be the 
predominant initiating mechanism in human cells (Boehm et al., 2014). In the latter decay 
pathway, Smg6 cleaves its substrate mRNAs in the vicinity of PTCs and the resulting 5’ 
and 3’ fragments are degraded by the exosome and Xrn1, respectively (Boehm et al., 
2014; Eberle et al., 2009; Huntzinger et al., 2008).  
Depending on the organism or cell type, about 5 to 20% of the transcripts in a 
typical transcriptome are substrates of NMD (He et al., 2003; Lelivelt and Culbertson, 
1999; Mendell et al., 2004; Ramani et al., 2009; Rehwinkel et al., 2005; Weischenfeldt et 
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al., 2008) and these transcripts can be classified into several general categories. One 
category, exemplifying typical NMD substrates, includes mRNAs with a destabilizing 
premature termination codon (PTC) in their coding region. These transcripts are 
generated from endogenous genes harboring nonsense or frameshift mutations (He et 
al., 2003), pseudogenes (He et al., 2003; McGlincy and Smith, 2008), non-productively 
rearranged genetic loci (Li and Wilkinson, 1998), or from alternative splicing events that 
lead to intron retention or inclusion of a PTC-containing exon (Jaillon et al., 2008; Lareau 
et al., 2007; Lykke-Andersen et al., 2014; Ni et al., 2007). A second category contains 
mRNA-like transcripts with limited or no apparent coding potential, such as long 
noncoding RNAs (Kurihara et al., 2009; Lykke-Andersen et al., 2014; Tani et al., 2013), 
small RNAs derived from intragenic regions (Smith et al., 2014; Thompson and Parker, 
2007), or transcripts of inactivated transposable elements (He et al., 2003). A third 
category contains a subset of physiologically relevant transcripts that appear to be 
“normal,” such as mRNAs with upstream open reading frames (uORFs) (Arribere and 
Gilbert, 2013; Gaba et al., 2005; He et al., 2003), or with atypically long 3’-UTRs (Kebaara 
and Atkin, 2009; Singh et al., 2008), or normal-looking wild-type mRNAs with no atypical 
features (He et al., 2003).  
To generate a comprehensive and high resolution catalog of NMD-regulated 
transcripts, and to delineate the defining features of these transcripts in NMD targeting, 
we utilized RNA-Seq to re-evaluate the effects of deleting the UPF1, UPF2, or UPF3 
genes on the transcriptome-wide expression of annotated yeast genes. Our new analyses 
confirm previous results of microarray studies, but also uncover hundreds of new NMD-
regulated transcripts that had escaped previous detection, including many intron-
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containing pre-mRNAs. Our bioinformatics analyses reveal several intrinsic features of 
NMD-regulated transcripts, yield new insights into the mechanisms by which translation 
of these transcripts targets them for NMD, and provide strong support for the notion that 
transcripts can become NMD substrates at any time during their translational life cycle.  
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RESULTS 
 Upf1, Upf2, and Upf3 regulate a common set of transcripts in yeast cells 
To obtain a high resolution catalogue of yeast NMD substrates, we analyzed 
expression profiles of wild-type (WT), upf1, upf2, and upf3 strains. RNA-Seq libraries 
were prepared from these strains in three biological replicates and the sequence reads 
from each library were aligned to: 1) a yeast transcriptome comprised of 7473 transcripts, 
including all annotated protein-coding sequences, functional and non-coding RNAs, and 
the unspliced isoforms of all intron-containing mRNAs and 2) a separate transcriptome 
comprising all 3569 CUT, SUT, and XUT transcripts annotated previously (Wery et al., 
2016). We opted to use two separate transcriptomes because combining them resulted 
in a substantial loss of power to detect differential expression.  Further investigation 
revealed that overlapping annotations were the principal cause: 1655 out of 3569 
genomic coordinates of CUT, SUT, and XUT sequences had some extent of overlap, 
sometimes with multiple annotations (2024 total overlaps).  Less than 1% of reads 
mapping to CUTs, SUTs, and XUTs were unique, compared to >55% for other transcripts. 
Based on posterior probabilities calculated by the RSEM software tool (Li and Dewey, 
2011), including CUTs, SUTs, and XUTs in a combined analysis would have resulted in 
a substantial increase in read count quantification error for all transcripts, compromising 
dispersion estimates used for subsequent differential expression calculations (Anders 
and Huber, 2010; Robinson et al., 2010). Similarly, because of their repetitive nature, we 
also excluded autonomous replicating sequences and long terminal repeats of 
transposable elements from our analysis.  
48 
 
We used RSEM (Li and Dewey, 2011) for transcript quantification and the DESeq 
R package (Anders and Huber, 2010) for differential expression analysis. To account for 
replicate variability, we used a false discovery rate threshold of 0.01 instead of arbitrary 
fold-change as a criterion for differential expression. All libraries exhibited similar 
distributions of read counts with few outliers (Fig. 2.1A) and biological replicates were 
extremely consistent, with Pearson correlation coefficients ranging from 0.84 to 0.99 (Fig. 
2.2). We refer to the set of sequences that contains all annotated transcripts except for 
CUTs, SUTs, and XUTs as transcriptome 1 (T1) and the set with the sequences for CUTs, 
SUTs, XUTs as transcriptome 2 (T2).  
 Deletion of UPF1, UPF2, or UPF3 led to differential expression of a subset of 
transcripts in yeast cells. In each of the UPF deletion strains, the vast majority of 
differentially expressed transcripts were up-regulated and only a small number of 
transcripts were down-regulated (Figs. 2.1B-D). The number of up- or down-regulated 
transcripts in individual UPF deletion strains were comparable and exhibited substantial 
overlap (Figs. 2.1B, C). These results indicate that the three Upf factors control the 
expression of a common set of transcripts in yeast cells. In transcriptome 1, we identified 
907 transcripts that were up-regulated and 29 that were down-regulated upon UPF 
deletion; under the same circumstances transcriptome 2 had 332 up-regulated transcripts 
(including 8 CUTs, 114 SUTs, and 210 XUTs; Table 2.1) and 124 down-regulated 
transcripts (Figs 2.1B). Pairwise comparisons of read counts for each of the 1392 
differentially expressed transcripts in upf1, upf2, and upf3 cells manifested almost 
equivalent expression values in each case (Fig. 2.1E), indicating that deletion of UPF1, 
UPF2, or UPF3 has almost identical quantitative effects on NMD-regulated transcripts 
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Figure 2.1. Upf1, Upf2, and Upf3 regulate the same set of transcripts in yeast.  
A. RNA-Seq libraries from WT, upf1, upf2, and upf3 strains display comparable overall read 
count distributions for both transcriptome 1 (T1; left panel) and transcriptome 2 (T2; right panel). 
Violin and box-plots were used to visualize the average sequence reads distribution of the 
transcriptomes of the indicated strains from three independent experiments. B. and C. 
Transcripts up- and down-regulated in upf1, upf2 and upf3 strains show significant overlap. 
Transcripts up- or down-regulated in each of UPF deletion strains were identified by 
comparisons to the WT strain. Venn diagrams were used to display the relationships among 
the sets of transcripts that are up-(B) and down-(C) regulated in T1 or T2 of upf1, upf2, and 
upf3 strains. D. All three UPF deletion strains display similar genome-wide expression 
patterns. Scatterplots were used to compare the read count values of differentially expressed 
transcripts between WT and upf1, upf2, or upf3 strains. The vast majority of differentially 
expressed transcripts in UPF deletion strains showed up-regulation and a small number of 
transcripts showed down-regulation. The y=x line is shown in red. Top panel: pairwise 
comparisons of the expression levels between WT and each UPF deletion strain for 936 
differentially expressed transcripts from transcriptome 1. Bottom panel: pairwise comparisons 
of the expression levels between WT and each UPF deletion strain for 456 differentially 
expressed transcripts from transcriptome 2. E. Transcripts commonly regulated by NMD each 
have virtually identical expression values in upf1, upf2, or upf3 strains. As in D, scatterplots 
were used to compare the read count values of NMD-regulated transcripts between upf1 and 
upf2, upf1 and upf3, and upf2 or upf3 strains. Top panel: differentially expressed 
transcripts from transcriptome 1. Bottom panel: differentially expressed transcripts from 
transcriptome 2. 
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Figure 2.2. RNA-Seq libraries generated from WT, upf1, upf2, upf3, dcp1, dcp2, 
and xrn1 strains show good reproducibility and correlation between biological 
replicates.  
The figure depicts pairwise scatterplot comparisons of estimated read counts for all transcripts 
in either transcriptome 1(left panel) or transcriptome 2 (right panel) between different biological 
replicates of the same strains. The y=x line in red and the Pearson correlation coefficient for 
pairwise comparison are indicated in each plot. 
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Table 2.1.  Different categories of transcripts that were analyzed, detected, and 
commonly up- or down-regulated in all three UPF deletion strains. 
Sequence reads from individual libraries of WT, upf1, upf2, and upf3 strains were 
separately mapped to transcriptomes 1 and 2 using the differential expression pipeline 
summarized in Methods. Transcripts differentially expressed in upf1, upf2, and upf3 strains 
were identified using the Bioconductor DESeq package. Comparisons to the WT strain were 
based on three independent experiments. The first nine categories of transcripts were from 
transcriptome 1 and the last three categories of transcripts were from transcriptome 2.  
* uORF-containing transcripts based on the annotations of Ingolia et al. (2009). 
** Transcripts annotated as non-coding including rRNAs, snRNAs, snoRNAs, and antisense 
regulatory RNAs, but not tRNAs. 
*** Most tRNAs are detected at extremely low levels and their read count values are probably 
unreliable as our RNA-Seq library construction protocol has a strong bias against small RNAs.  
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These results strengthen the idea that, at least in yeast, Upf1, Upf2, and Upf3 have 
equivalent effects on the execution of a single NMD pathway (He et al., 1997). 
Transcripts regulated by NMD have also been identified in previous analyses (He 
et al., 2003; Johansson et al., 2007; Malabat et al., 2015; Sayani et al., 2008; Smith et 
al., 2014) and we sought to compare our new transcript lists to those generated earlier. 
However, naming conventions for Affymetrix microarray probes are not completely 
consistent with annotated gene names and a significant fraction (~20%) of transcripts 
represented by microarray probes are not in our new reference transcriptomes. 
Therefore, we restricted our comparisons to microarray probes that have definitively 
matched transcripts in our transcriptomes. As shown in Table 2.2, there is substantial 
overlap (>60%) with our results and previously published datasets. These results indicate 
that our RNA-Seq analyses yielded comprehensive sets of NMD-regulated transcripts in 
yeast cells that include the majority of transcripts identified by previous analyses and 
numerous transcripts that were not detected in previous studies. Transcripts commonly 
up-regulated in all three UPF deletion strains did not show any significant enrichment for 
those encoding factors involved in signal transduction or transcriptional regulation and, 
although a handful of up-regulated transcripts encode transcription factors, the annotated 
targets for each of these transcription factors were not particularly enriched in our NMD-
regulated transcript list. Although we cannot definitively rule out indirect effects that alter 
mRNA abundance, these observations and the known roles of  the three Upf factors as 
positive regulators of NMD (He and Jacobson, 2001) suggest that the 1239 transcripts  
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Table 2.2. Overlap of NMD-regulated transcripts identified in this study and in several 
previous studies. 
RNA-Seq analyses in this study identified 1239 transcripts commonly up-regulated in all three 
UPF deletion strains. This set of transcripts was compared to several other previously published 
datasets (He et al., 2003; Johansson et al., 2007; Malabat et al., 2015; Sayani et al., 2008; 
Smith et al., 2014) which had the following key features: He et al. – this list, identified by 
microarray analysis, includes the common set of transcripts  upregulated in response to single 
UPF deletions; Johansson et al. -  this list, identified by microarray analysis, includes the set of 
transcripts that are down regulated upon transcriptional activation of a galactose-regulated 
UPF2 gene; Sayani et al. – this list, identified using tiling arrays, includes intron-containing 
transcripts that were >2x-upregulated in upf1∆ strains; Smith et al. – this dataset was generated 
using the bioinformatics pipeline described in this study and two independent RNA-Seq 
experiments from WT and upf1∆ strains; and Malabat et al. – the authors’ analyses employed 
an FDR of 1% to identify the set of transcripts upregulated in upf1∆ cells.  
 
56 
 
commonly up-regulated in the two transcriptomes analyzed here likely constitute direct 
substrates of NMD. Because of the ambiguity of read alignments and lack of information 
about the biological role of CUT, SUT, and XUT sequences in the literature, most of our 
subsequent analyses were focused on the 907 up-regulated transcripts present in 
transcriptome 1.  
 Structural and functional classes of NMD-regulated RNAs in transcriptome 1 
To gain insight into the mechanism targeting well annotated NMD substrates, we 
classified the NMD-regulated transcripts of transcriptome 1 into their respective structural 
and functional categories. Among the 907 up-regulated transcripts of transcriptome 1, 
902 were from annotated protein-coding genes and 5 were from annotated “non-coding” 
RNA genes (Table 2.1). Since NMD requires ongoing translation (Hu et al., 2010; Zhang 
et al., 1997), our observation that some “non-coding” RNAs of transcriptome 1 are 
substrates of NMD suggests that these transcripts are actually translated and may 
encode bona fide polypeptides. Among the 902 NMD-regulated transcripts coming from 
protein coding genes, 88% appear to be “normal” mRNAs and to lack any structural 
features indicative of substrates of NMD (see below). The remaining 12% can be 
classified into five known structural classes of NMD substrates (He et al., 2003), namely: 
1) mRNAs encoded by genes harboring nonsense mutations in their coding regions (e.g., 
CAN1, LEU2), 2) mRNAs utilizing frameshiftting in their translation (e.g., YGR109W-B, 
YIL082W-A, and YIL009C-A), 3) transcripts originated from pseudogenes (e.g. 
YAR061W, YFL056C, YOL153C), 4) mRNAs that contain annotated and putative 
upstream open reading frames (Ingolia et al., 2009) (uORFs; e.g., CPA1), and 5) pre-
mRNAs that retain their introns and enter the cytoplasm as a consequence of inefficient 
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or regulated splicing (e.g., RPL22B, RPL24B, HRB1). The latter two classes (uORF-
containing mRNAs and intron-containing pre-mRNAs) were enriched significantly in NMD 
substrates: 89 out of 356 putative uORF-containing yeast transcripts (Ingolia et al., 2009) 
and 57 out of 351 potential intron-containing pre-mRNAs were present at a higher ratio 
than would be expected by chance (chi-square p=4.8 x 10-9 and 0.0006, respectively). 
Our observation that NMD targets a large number of intron-containing pre-mRNAs 
indicates that there is a widespread entry of intron-containing transcripts into the yeast 
cytoplasm and that, in yeast, NMD plays a general role in the degradation of a subset of 
intron-containing pre-mRNAs. 
 Validation of newly identified NMD substrates 
 To validate our RNA-Seq and bioinformatics results, we assessed the levels of 
expression of seven newly identified NMD-regulated transcripts in wild-type, upf1, 
upf2, and upf3 strains by northern blotting. To ascertain NMD substrate specificity, we 
also analyzed yeast strains harboring single deletions of genes encoding the major 
cytoplasmic 5’ to 3’ exonuclease (Xrn1), the Dcp1/Dcp2 decapping enzyme, and several 
decapping activators (Edc3, Pat1, Lsm1, Dhh1, and Scd6). Among the seven selected 
NMD-regulated transcripts analyzed, four (HRB1, RPL22B, NHP6B, MTR2) are intron-
containing pre-mRNAs, two are annotated as “non-coding” RNAs, and one utilizes 
frameshifting during translation (Ty4 transposon). Of the intron-containing pre-mRNAs, 
two (HRB1, RPL22B) contain an intron in their coding regions and two (NHP6, MTR2) 
contain an intron in their 5’-UTRs. As a negative control, we analyzed the intron-
containing HAC1 pre-mRNA in these strains. All seven NMD-regulated transcripts 
showed the expected expression patterns in these yeast strains (Fig. 2.3, A-C).  
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Figure 2.3. Validation of several different classes of NMD substrates by northern 
blotting.  
Northern blotting analyses of: A. Intron-containing transcripts (HRB1, RPL22B, NHP6B 
and MTR2), B. Transcripts using frameshifting during translation (Ty-4 transposons), 
C. “non-coding” RNAs (ICR1 and IRT1), and D. negative control transcripts (HAC1 pre-
mRNA). Total RNA was isolated from the indicated strains and the steady-state levels 
of individual transcripts in these strains were analyzed by northern blotting. In each 
case, a random-primed probe was hybridized to the blot and SCR1 served as the 
loading control.  
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Compared to their expression in wild-type cells, each of these transcripts showed 
increased levels in upf1, upf2, and upf3 strains, and also in xrn1, dcp1, and dcp2 
strains. However, the levels of expression of each of these transcripts were unchanged 
in edc3, pat1, lsm1, dhh1, and scd6 strains. The levels of the HAC1 pre-mRNA 
were essentially unchanged in all the deletion strains. Collectively, these observations 
confirm that all seven transcripts are NMD-regulated and degraded through decapping 
and 5’ to 3’ exonucleolytic decay. The latter results mirror our analyses of RNA-Seq data 
(see below).   
 NMD substrates are principally degraded by decapping and 5’ to 3’ 
exonucleolytic decay 
 Several NMD substrates have previously been shown to be degraded by 
decapping and 5’ to 3’ exonucleolytic degradation (He and Jacobson, 2001; Muhlrad and 
Parker, 1994), including those analyzed in Fig. 2.3. To evaluate the prevalence of this 
mechanism in NMD at a transcriptome-wide level, we analyzed the expression patterns 
of the 907 NMD regulated transcripts of transcriptome 1 in dcp1, dcp2, and xrn1  
strains we prepared RNA-Seq libraries from dcp1, dcp2, and xrn1 strains and 
subjected them to the same analysis pipeline as described above for libraries prepared 
from upf strains. These libraries showed similar consistencies and read count distributions 
as single WT and UPF deletion libraries (Fig. 2.4 A; Fig 2.2). Consistent with current 
concepts of the roles of Dcp1, Dcp2, and Xrn1 in NMD and general 5’ to 3’ decay (Parker, 
2012), deletion of DCP1, DCP2, and XRN1 each caused up-regulation of >1,000 
transcripts (Fig. 2.4 B). As expected, the up-regulated transcripts in dcp1, dcp2, and 
xrn1 strains had significant overlap, with overlapping fractions ranging from 52% to 88% 
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Figure 2.4. NMD substrates are principally degraded by decapping and 5’ to 3’ 
exonucleolytic decay.  
A. RNA-Seq libraries from WT, dcp1, dcp2, and xrn1 strains display normal and 
comparable overall read count distributions. As in Fig. 2.1 A, violin and box-plots were 
used to visualize the average sequence reads distribution of the transcriptomes of the 
indicated strains from three independent experiments. B. Transcripts up- or down-
regulated in dcp1, dcp2, and xrn1 strains show significant overlap. Transcripts up- 
or down-regulated in dcp1, dcp2, and xrn1 strains (upper and lower panels, 
respectively) were identified by comparisons to the WT strain. C. Transcripts commonly 
up- or down-regulated from transcriptome 1 in all three UPF deletion strains show 
significant overlap with transcripts up-regulated in both in dcp1Δ and dcp2Δ strains or 
an xrn1Δ strain. Venn diagrams were used to display the relationships among the up- 
or down-regulated transcripts from the indicated strains.  
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 (Fig. 2.4 B). The 907 NMD-regulated transcripts had significant overlap with transcripts 
that were up-regulated in both dcp1 and dcp2 cells or xrn1 cells (Fig. 2.4 C). Overall, 
approximately 70% of NMD-regulated transcripts had increased levels of expression in 
dcp1, dcp2, and xrn1 strains. Consistent with our earlier microarray analyses (He et 
al., 2003), these results indicate that yeast NMD substrates are largely but probably not 
exclusively degraded by decapping and 5’ to 3’ exonucleolytic decay.  
 Intron-containing pre-mRNAs targeted by NMD are engaged in translation 
 To further elucidate the role of NMD in the degradation of intron-containing pre-
mRNAs, we analyzed ribosome occupancy within the intronic regions of pre-mRNAs 
targeted by NMD (n=57) and those that are not (n=244). Using published ribosome 
profiling data (Young et al., 2015), we measured ribosome densities (coverage 
profiling/coverageRNA-Seq) within the intronic regions for these two groups of intron-containing 
transcripts. We found that introns from the pre-mRNAs targeted by NMD do in fact show 
a subtle, but statistically significant, higher ribosome occupancy than introns from the pre-
mRNAs not targeted by NMD (two sample K.S. test p=0.038; Figs. 2.5 A, B). These 
results indicate that intron-containing pre-mRNAs targeted by NMD are generally 
engaged in translation. In support of this conclusion, several of these NMD-targeted pre-
mRNAs were previously shown to be associated with polyribosomes (He et al., 1993).  
 NMD substrates similar to normal mRNAs are poorly translated regardless 
of the NMD status of the cell 
 The compilation of a comprehensive list of NMD substrates raises the general 
question of what dictates NMD specificity for these transcripts. While the NMD targeting  
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Figure 2.5. NMD targeted intron-containing pre-mRNAs are engaged in 
translation.  
A. Cumulative density plot of ribosome density of the intronic regions for pre-mRNAs 
targeted (blue, n=57) or not targeted (red, n=244) by NMD. This plot illustrates the 
fraction (on the Y axis) of transcripts having the indicated ribosome densities (on the x 
axis). B. Distribution of mean ribosome densities over normalized intronic regions for 
the same two sets of intron-containing transcripts as in A. Plots in A and B were derived 
from the ribosome profiling data of WT cells by Young et al. (2015). Ribosome densities 
were calculated as profilingcoverage / RNA-Seqcoverage for each intron. Introns of NMD-
targeted pre-mRNAs show higher ribosome densities than introns of the pre-mRNAs 
that are not targeted by NMD (two sample K.S. test p=0.038). 
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Figure 2.6. NMD substrates are less efficiently translated than non-substrates 
independent of the NMD machinery. 
A. Cumulative density plots of ribosome densities derived from ribosome profiling data 
of WT cells for normal-looking NMD substrates (blue n=746) and non-NMD substrates 
(red=4633). B. Mean ribosome densities over normalized ORFs derived from the same 
data and for the same two sets of transcripts shown in A. C. Cumulative density plots 
of ribosome densities derived from the same data in A for uORF-containing transcripts 
targeted (dashed, blue n=42 NMD) or not targeted (dashed, red n=199 by NMD and for 
uORF-lacking transcripts targeted (solid, blue n=704) or not targeted (solid, red 
n=4434) by NMD. D. Cumulative density plots of ribosome densities derived from other 
ribosome profiling datasets of WT (solid) and upf1 (dashed) cells for normal-looking 
NMD substrates (blue) and non-NMD substrates (red) shown in A. Plots in A, B, and C 
were derived from the ribosome profiling data of Young et al (2014) and plots in D were 
derived from the ribosome profiling data of Smith et al (2015). Ribosome densities were 
calculated as profilingcoverage / RNA-Seqcoverage for each transcript. Two-sample K.S. test 
p values are described in the results section.  
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of PTC-, uORF-, and intron-containing transcripts, and “non-coding” RNAs, can all be 
attributed to premature translation termination, the vast majority (almost 90%) of NMD 
substrates in transcriptome 1 are protein-coding transcripts that look like normal, wild-
type mRNAs. To identify potential features associated with this “normal-looking” group of 
NMD substrates, we evaluated several parameters, including 5’-UTR, ORF, and 3’-UTR 
lengths, and ribosome densities, for this group of NMD substrates and compared these 
parameters to those generated from protein-coding mRNAs not subject to NMD 
regulation. Using previously published annotations (Nagalakshmi et al., 2008; Pelechano 
et al., 2013; Xu et al., 2009), we observed conflicting results for the potential role of UTR 
lengths in substrate selection. Using the annotations of Nagalakshmi et al., we found no 
discernible difference between 5’- and 3’-UTR lengths of normal-looking mRNAs targeted 
vs. not targeted by NMD, while the annotations of Pelechano et al UTRs are longer for 
NMD substrates and the annotations of Xu et al. suggested that 5’-UTRs are shorter for 
NMD substrates (data not shown). These conflicting annotations precluded any 
conclusions about the role of UTR lengths in the determination of NMD substrate status. 
However, by comparing the published (Young et al., 2015) ribosome occupancies of 
these subsets of transcripts we observed a striking difference in normalized ribosome 
occupancy in wild-type cells. The normal-looking NMD substrates had significantly lower 
ribosomal density throughout their open reading frames than the non-NMD substrates 
(two sample K.S. test p<2.2e-16) (Figs. 2.6 A, B, blue and red lines, respectively). Based 
on this observation, we also analyzed the normalized ribosome occupancy of all putative 
uORF-containing transcripts. We separated the transcripts into two different groups: 
those regulated by NMD and those not regulated by NMD. Much like the normal-looking 
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NMD substrates, the NMD-regulated uORF-containing transcripts also exhibited lower 
ribosome densities than those not subject to NMD regulation (Fig. 2.6 C; two sample K.S. 
test p<2.2e-16 and p=3.57e-10 for transcripts without and with uORFs, respectively). 
Together, these results indicated that NMD substrates are probably translated less 
efficiently than non-NMD substrates.  
In addition to triggering rapid transcript degradation, recognition of an mRNA as 
an NMD substrate has been suggested to lead to concomitant Upf1-dependent 
translational repression (Muhlrad and Parker, 1999b). To assess whether the observed 
lower ribosome density of normal-looking NMD substrates in wild-type cells reflected this 
phenomenon, we utilized published ribosome footprinting libraries (Smith et al., 2014) to 
compare the normalized ribosome densities of NMD substrates in wild-type and upf1 
cells. These analyses demonstrated that the ribosome density profiles for both normal-
looking NMD substrates and non-NMD substrates showed similar differences in ribosome 
density regardless of the strain (Fig. 2.6 D; two sample K.S. test p<2.2e-16 for both WT 
and upf1, between NMD substrates and non-substrates), i.e., the NMD substrates were 
also translated less efficiently in upf1 cells. Collectively, our bioinformatics analyses 
indicate that low ribosome density is an intrinsic property of NMD-targeted transcripts. 
 Normal-looking NMD substrates have a higher rate of out-of-frame 
translation 
 The comparatively reduced ribosome densities of NMD substrates observed in Fig. 
2.6 suggested that these mRNAs may share a common impairment. We thus tested 
whether normal-looking NMD substrates and non-NMD substrates may have different  
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Figure 2.7. NMD substrates have lower translation fidelity and lower codon 
optimality 
A. Cumulative density plots of in-frame read ratios over total reads derived from 
ribosome profiling data of WT cells for intron-lacking NMD substrates (n= 746, blue) 
and non-NMD substrates (n=4633, red). B. Cumulative density plots of mean codon 
optimality scores for two sets of transcripts shown in A. C. Mean transition probabilities 
of a two-state discrete time Markov chains between optimal (O) and non-optimal (N) 
codons for intron-lacking NMD substrates (blue) and non-NMD substrates (red). D. 
Distributions of Markov chain codon transition probabilities for intron-lacking NMD 
substrates (blue) and non-NMD substrates (red). Plots in A were derived from the 
ribosome profiling data of Young et al (2014) and plots in B, C, and D were based on 
codon optimality assignments and scores published by Pechmann and Frydman 
(2013). Two-sample K.S. test p values are described in the results section.  
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Figure 2.8. Transcripts upregulated upon UPF deletion have lower ribosome 
densities and higher out-of-frame translation regardless of iTSSs. 
A. Filtering schemes employed to identify iTSS-containing transcripts in the dataset of 
Malabat et al. (2015) and subsequent two sample K.S. between different subsets of 
transcripts. Padj, unphased: includes genes that have an out of frame AUG as the first 
methionine, and that isoform is differentially expressed in upf1∆ strains with the 
indicated FDR cutoff; Total fold change: the fold change cutoff in the total number of 
reads mapping to any kind of transcription start site in WT and upf1∆ strains; Unphased 
fold change: fold change in the number of reads that map to a TSS that is in a different 
frame than the annotated start site;  Has iTSS: genes that contain iTSSs, according to 
authors; No uORF: genes that do not contain uORFs, according to authors. Two 
sample K.S. tests between NMD substrates and non- substrates for out of frame read 
ratios and ribosome occupancies that do or do not contain iTSSs B. Overlap of NMD 
substrates and transcripts that were identified as having iTSSs by Pelechano et al. 
(2013) and Malabat et al. (2015). C. Ratio of out of frame reads in previously published 
ribosome footprint profiling datasets (Young et al., 2015). Blue lines indicate NMD 
substrates and red lines indicate non-NMD substrates. Solid lines indicate genes that 
did not pass the filtering cited in column A and dashed lines indicate the genes that did. 
D. Similar to C with ribosome occupancies.  
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amounts of out-of-frame translation in their coding regions. For this analysis, we analyzed 
published (Young et al., 2015) ribosome profiling data and only used read lengths that 
displayed a strong preference (>80% of reads) for one frame, mapping these sequence 
reads to NMD and non-NMD-regulated transcripts. We calculated the ratio of out-of-frame 
reads to total mapped reads for each of these transcripts and compared the out-of-frame 
ratio distributions between the normal-looking NMD and non-NMD populations. This 
analysis indicated that the NMD-regulated transcripts showed a significantly higher ratio 
of out-of-frame reads (Fig. 2.7 A; two sample K.S. test p<2.2e-16). These results indicate 
that in addition to lower ribosome density, NMD substrates also exhibit higher out-of-
frame read ratios and thus a higher rate of out-of-frame translation. One potential 
explanation for increased out-of-frame translation could be that these genes have internal 
transcription start sites (iTSSs) and the subsequent isoforms are the main substrates for 
NMD. To test this hypothesis, we used iTSS-containing gene lists published by two 
independent groups (Malabat et al., 2015; Pelechano et al., 2013). We compared the 
overlaps between transcripts with iTSSs and our list of NMD substrates. Interestingly, we 
found little overlap between these three groups of transcripts. In addition, when we 
compared the ribosome densities and out-of-frame read ratios between transcripts that 
have been suggested to have iTSSs by Malabat et. al. and those that don’t we observed 
similar differences between NMD substrates and non-substrates. That is, regardless of 
iTSS status, transcripts that we have identified as NMD substrates show higher rates of 
out-of-frame translation and lower ribosome densities (Fig. 2.8). 
 Normal looking NMD substrates have lower average codon optimality and a 
biased distribution pattern of non-optimal codons  
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 To further understand the basis of lower ribosome density and increased out-of-
frame translation of NMD substrates, we explored potential differences in codon usage 
for normal looking NMD and non-NMD-regulated transcripts. We used published codon 
optimality data (Pechmann and Frydman, 2013), to calculate average codon optimality 
scores for both NMD and non-NMD-regulated transcripts, and compared the score 
distributions of these two populations. We found that the NMD-regulated transcripts had 
a subtle, but statistically significant lower average codon optimality score (Fig. 2.7 B; two 
sample K.S. test p=3.9e-7). Based on this finding, we then recoded the codon sequences 
of each NMD- and non-NMD-regulated transcript as a binary series of optimal (O) or non-
optimal (N) codons, treated each recoded transcript as a discrete time Markov chain, and 
calculated the transition probabilities from one state to another for each transcript (i.e., O 
to O, O to N, N to N, and N to O). We then compared the distributions of transition 
probabilities of the NMD and non-NMD-regulated transcripts. We found that NMD-
regulated transcripts again showed a subtle but statistically significant preference towards 
non-optimal codons (i.e., having higher N to N and O to N, but lower N to O and O to O 
transition probabilities; two sample K.S. test p=2.4e-7, 1.2e-7, 5.4e-14, 5.3e-14, 
respectively; Figs. 2.7 C, D). Our analyses thus indicated that, as individual metrics, 
average codon optimality and N to N and O to O transition probabilities all seem to 
contribute to NMD susceptibility. Because average codon optimality is highly correlated 
with transition probabilities we were unable to conclude whether NMD substrates still had 
a higher tendency to exhibit longer stretches of non-optimal codons when controlled for 
overall codon optimality.  
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DISCUSSION 
 A comprehensive catalog of annotated yeast NMD substrates 
Using RNA-Seq analyses, we have redefined the set of transcripts regulated by 
NMD in Saccharomyces cerevisiae. Our new comprehensive list of yeast NMD substrates 
originates from the well annotated genes of transcriptome 1 and includes the vast majority 
of NMD-regulated transcripts identified by previous analyses (He et al., 2003; Johansson 
et al., 2007; Malabat et al., 2015; Sayani et al., 2008; Smith et al., 2014), as well as 
hundreds of new transcripts that escaped prior detection. While many CUTs, SUTs, and 
XUTs of transcriptome 2 manifest changes in abundance in response to inactivation of 
each Upf factor the relevance of these transcripts to the conventional understanding of 
NMD remains obscure, particularly in light of the lack of precise mapping information for 
these transcripts. Accordingly, our attention has largely been drawn to the components 
of transcriptome 1. Consistent with the positive roles of Upf1, Upf2, and Upf3 in NMD 
activation (He and Jacobson, 2015b; Kervestin and Jacobson, 2012), almost all NMD 
substrates in the transcriptome 1 list are up-regulated by NMD inactivation, with only a 
handful of transcripts showing down-regulation under the same conditions. Further, the 
strict requirement for translation in NMD activation (Hu et al., 2010; Zhang et al., 1997) 
was reflected in the observation that 99% of the NMD substrates in transcriptome 1 were 
annotated as protein coding transcripts. 
Each of the up-regulated transcripts shares a nearly identical quantitative response 
to deletion of the UPF1, UPF2, or UPF3 genes and exhibits comparable expression levels 
in the three UPF deletion strains (Fig. 2.1 E). In addition, most transcripts in the up-
regulated group also exhibit increased accumulation upon inactivation of the Dcp1/Dcp2 
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decapping enzyme and the 5’ to 3’ Xrn1 exonuclease (Fig. 2.4 C), two critical components 
that function downstream the yeast NMD pathway (Parker, 2012). The set of up-regulated 
transcripts also includes several known structural classes of NMD substrates including 
mRNAs encoded by genes harboring nonsense mutations in their coding regions, mRNAs 
utilizing frameshifting in their translation, pseudogene transcripts, mRNAs that contain 
uORFs, and pre-mRNAs that retain their introns and enter the cytoplasm as a 
consequence of inefficient or regulated splicing (Fig. 2.9 A). Collectively, these 
observations lead us to conclude that the bulk of the up-regulated transcripts identified 
here are likely to be bona fide substrates of the NMD pathway in yeast cells.  
 A significant fraction of yeast intron-containing mRNAs are targeted by 
cytoplasmic NMD 
In addition to generating a comprehensive catalog of yeast NMD substrates, our RNA-
Seq analyses also revealed that a significant fraction (~16%) of yeast intron-containing 
genes produce intron-containing pre-mRNA isoforms that are engaged with translating 
ribosomes and subject to NMD regulation (Fig. 2.5; Table 2.1). These observations 
indicate that, even under normal growth conditions, a significant fraction of intron-
containing pre-mRNAs are exported from the nucleus to the cytoplasm, where they are 
degraded by NMD. The large number of yeast intron-containing pre-mRNAs subject to 
NMD regulation suggests that NMD plays a much more significant than anticipated role 
in intron-containing pre-mRNA degradation in yeast cells. Consistent with this conclusion, 
previous tiling microarray analyses also revealed a large overlapping set of intron-
containing pre-mRNAs subject to NMD (Sayani et al., 2008). 
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Figure 2.9. Different classes of NMD substrates.  
A. “Traditional” NMD substrates. Translation of these NMD substrates commences at 
initiation codons located at ORF (or uORF) 5’ ends, proceeds 3’, and leads to an in-
frame encounter with a coding region premature termination codon. Transcripts in this 
class include mRNAs derived from nonsense alleles, pre-mRNAs that enter the 
cytoplasm with unspliced introns, uORF-containing mRNAs, mRNAs in which 
programmed frameshifting allows a fraction of ribosomes to avoid premature 
termination, and mRNAs transcribed from pseudogenes. B. “Probabilistic” NMD 
substrates. These NMD substrates lack in-frame premature termination codons in their 
coding regions, but contain mRNA features that promote either downstream out-of-
frame translational initiation or frameshifting and thus trigger premature termination in 
a new reading frame. Transcripts in this category include mRNAs with poor sequence 
context around the normal initiation codon, mRNAs whose transcription start site is 
internal to the principal ORF, and mRNAs with lower overall codon optimality or a long 
stretch of non-optimal codons (NOCs). In each of these cases, a subset of ribosomes 
translate the mRNA in a frame different from that of the annotated ORF. 
Green=initiation codon; red=stop codon; yellow=UTR; purple=stop codon encountered 
in the +1 or +2 reading frame; blue=cluster of non-optimal codons.  
76 
 
 Potential targeting mechanisms of the normal-looking NMD substrates 
The largest fraction of NMD substrates identified here is comprised of normal-
looking mRNAs that appear to lack defining features of premature termination. Our 
bioinformatics analyses reveal several intrinsic properties of these normal-looking NMD 
substrates that suggest a potential NMD-targeting mechanism. Compared to non-NMD 
substrates, this group of mRNAs has lower translation efficiency, a higher rate of out-of-
frame translation, lower average codon optimality, and a propensity to have stretches of 
non-optimal codons. Further, in contrast to an earlier proposition (Isken et al., 2008; 
Muhlrad and Parker, 1999b), the lower translation efficiency for this group of substrates 
appears to be independent of the NMD machinery. 
The intrinsic properties that we uncovered for the normal-looking NMD substrates 
could reflect direct causes or indirect consequences of NMD targeting for these mRNAs, 
i.e., some of these properties may function independently or synergistically in NMD 
targeting. One possible mechanism of NMD targeting may be attributable to translational 
elongation through a stretch of non-optimal codons. The lower average codon optimality 
or longer stretches of non-optimal codons of the normal-looking NMD substrates might 
lead to less efficient translation for this group of transcripts, an increased probability that 
an error will be made during translation elongation, and the observed higher rate of out-
of-frame translation. Clearly, the latter offers a greater likelihood for premature translation 
termination.  
The less efficient translation and the higher rate of out-of-frame translation that we 
observed for normal-looking NMD substrates could also be caused by events 
independent of the translation of a stretch of non-optimal codons. One possibility could 
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be heterogeneity in the primary structure of this group of NMD substrates, i.e., the normal-
looking NMD substrates may each have multiple transcript isoforms. Some of the 
isoforms may have very short 5’-UTRs (Arribere and Gilbert, 2013) and some of the 
isoforms may result from internal transcriptional initiation in protein coding regions 
(Malabat et al., 2015). These unusual isoforms could have lower efficiencies of translation 
initiation at conventional ORF start sites and higher rates of out-of-frame downstream 
translation initiation. However, the detection of such isoforms as NMD substrates in a 
transcriptome-wide study would require that they constitute a significant fraction of the 
mRNA isoform population for a particular gene. Significantly, the less efficient translation 
and the higher rate of out-of-frame translation that we observed for normal-looking NMD 
substrates are largely independent of iTSS status (Fig. 2.8). Similarly, alternative splicing 
events could also produce a subset of transcripts targeted by NMD, but previously 
reported alternative splicing events in yeast appear to generate only minor mRNA 
isoforms (Kawashima et al., 2014) and are thus unlikely to be detected as NMD substrates 
in our study.  Therefore, the less efficient translation and higher rates of out-of-frame 
translation of the normal-looking NMD substrates are unlikely to be caused by transcript 
isoform heterogeneities, and most likely originate from the intrinsic translation properties 
of these mRNAs. Further, their propensity for frameshifting is most likely the cause of 
subsequent premature termination and NMD substrate status. In short, NMD can serve 
as a probabilistic quality control mechanism that allows for detection of errors during 
translation elongation. Collectively, atypical transcription or translation initiation, or 
unexpected frameshifting events, could all be targeted by NMD. In each of these cases, 
NMD activation is linked to premature or premature-like translation termination, as 
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observed for several previously characterized classes of transcripts targeted by NMD 
(Fig. 2.9). This mode of action for NMD is consistent with previously published results in 
which NMD could target transcripts even after their first round of translation (Gaba et al., 
2005; Maderazo et al., 2003).  
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Regulation of mRNA decapping by competing factors 
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SUMMARY 
 mRNA decay is an important step in gene regulation and mRNA decapping can be 
a rate-limiting step in at least one major decay pathway. Decay rates of different 
transcripts show large variability, but the exact mechanism by which the Dcp1-Dcp2 
decapping complex is regulated is largely unknown. Several in vitro and in vivo studies 
have indicated that interactions among the set of decapping activator proteins and the C-
terminal extension of Dcp2 may target and activate the decapping complex, but the 
precise regulatory role of this network of interactions is unclear. To better understand how 
decapping regulation is achieved by the C-terminal extension of Dcp2 in Saccharomyces 
cerevisiae, we generated RNA-Seq libraries from a DCP2 allele, dcp2-N245, which lacks 
the sequence encoding the Dcp2 C-terminal domain, and from strains that harbor point 
mutations in the catalytic domain of this allele in conjunction with the C-terminal 
truncation. To understand the regulatory roles of the decapping activators, we also 
prepared and analyzed RNA-Seq libraries from strains that contain single deletions of the 
LSM1, PAT1, and DHH1 genes. Our transcriptome-wide results indicate that: 1) the Dcp2 
C-terminal extension is crucial for efficient regulation of decapping, 2) different decapping 
activators are responsible for targeting different sets of mRNAs, and 3) different 
decapping activators might compete for binding to the limited pool of cellular decapping 
enzyme. Further, our gene ontology analyses indicate that decapping activators are 
responsible for regulating specific biological processes, thus underscoring the biological 
importance of decapping regulation.  
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INTRODUCTION 
 Gene expression in eukaryotes is a tightly regulated process. From transcription 
to protein folding, every step of this pathway is subjected to scrutiny and modulation by 
numerous factors. One such step, mRNA decay, can be an effective means to regulate 
the extent of gene expression or to respond to rapid changes in the cellular environment 
(Holmes et al., 2004). Eukaryotic mRNAs are protected from nonspecific decay by two 
end-specific complexes: 1) the 5’-cap and its associated binding proteins and 2) the 
poly(A) tail and its binding partner, the poly(A)-binding protein (Mangus et al., 2003; Roy 
and Jacobson, 2013; Shoemaker and Green, 2012). Accordingly, transcripts targeted for 
decay by the predominant 5’ to 3’ or 3’ to 5’ exonucleolytic pathways are usually 
deadenylated by the Pan2-3 and Ccr4-Not complexes (Wahle and Winkler, 2013), and/or 
decapped by the Dcp1-Dcp2 complex (LaGrandeur and Parker, 1998; Steiger et al., 2003; 
Wang et al., 2002) prior to decay.  
 Dcp2 is the catalytic subunit of the decapping complex and this protein includes 
BoxA, Nudix, and BoxB motifs in an N-terminal domain occupying the first ~250 amino 
acids (Mugridge et al., 2016). The Nudix motif is responsible for catalysis of the decapping 
reaction (Dunckley and Parker, 1999, 2001) and BoxB is involved in RNA binding (She et 
al., 2006). While these Dcp2 N-terminal domains are well conserved, the C-terminal 
extensions beyond them show wide variability, from as short as ~170 amino acids in 
humans to ~700 amino acids in budding yeast (Wang et al., 2002). Dcp1 is a small protein 
that interacts with the BoxA motif of Dcp2 and contains a conserved EVH1 domain 
thought to be involved in modulating the binding of additional factors (She et al., 2004). 
Because the purified N-terminal fragment of Dcp2 is catalytically active and its activity is 
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greatly enhanced by Dcp1 (She et al., 2008; Steiger et al., 2003), most biochemical and 
structural studies have focused on truncated forms of Dcp2 (Arribas-Layton et al., 2013; 
Grudzien-Nogalska and Kiledjian, 2017). However, there is considerable evidence 
suggesting that decapping activators such as Pat1, Edc3, and the nonsense-mediated 
mRNA decay (NMD) regulator, Upf1, associate with Dcp2’s C-terminal region to regulate 
substrate recognition and decapping in vivo (He and Jacobson, 2015a). 
 An understanding of the precise roles of the decapping activators has remained 
elusive. While the mechanism of decapping activation of Dcp2 by decapping regulators 
is unclear, it has been suggested that binding of activators stabilizes the active 
conformation of the complex (Valkov et al., 2016). Indeed, the Dcp1-Dcp2 complex 
undergoes significant conformational changes from active to inactive states (Mugridge et 
al., 2016; She et al., 2008). At least in yeast, where a Dcp2 negative regulatory element 
is thought to prevent indiscriminate decapping, this inhibitory role is suppressed by the 
binding of decapping activators (He and Jacobson, 2015a). Decapping activators are also 
thought to provide substrate specificity to the decapping complex and deletion of their 
binding sites results in loss of substrate specificity (He and Jacobson, 2015a).  
One extensively studied decapping activator, the Lsm1-7 complex , along with its 
partner Pat1, which interacts with Lsm2 and Lsm3 (Sharif and Conti, 2013), is responsible 
for targeting mRNAs that have undergone significant poly(A) shortening (Nissan et al., 
2010; Tharun and Parker, 2001). Deletion of components of this complex results in the 
accumulation of deadenylated but capped decay intermediates (Tharun et al., 2000). 
Without Pat1, the Lsm1-7 complex loses its preference for mRNAs with shorter poly(A) 
tails (Chowdhury et al., 2014). The Lsm1-7 complex does not associate with the 
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decapping complex directly. That role is reserved for Pat1, which, in yeast, has multiple 
binding domains on the Dcp2 C-terminal extension, some of which overlap with Upf1 
binding sites (He and Jacobson, 2015a). Pat1 also associates with the 5’ to 3’ 
exonuclease Xrn1 (Nissan et al., 2010), an interaction also thought to promote mRNA 
decay.  
 Another well studied decapping regulator, Dhh1, is a conserved DEAD-box 
helicase (Presnyak and Coller, 2013). Recent evidence suggests that Dhh1 targets slowly 
translating mRNAs, possibly due to poor codon optimality (Radhakrishnan et al., 2016; 
Sweet et al., 2012). Tethering Dhh1 can result in even slower translation and subsequent 
decay in yeast (Sweet et al., 2012). Adding further complexity to the network of decapping 
regulators, Dhh1 can interact with Pat1 and Edc3, but their overlapping binding sites 
indicate that this interaction cannot happen concurrently (Tritschler et al., 2009a). While 
Dhh1 can associate with RNA effectively this interaction is inhibited upon Pat1 or Edc3 
binding (Sharif et al., 2013). These observations led to the hypothesis that there can be 
multiple decapping complexes in the cytoplasm, with different activators and different 
substrate specificities (He and Jacobson, 2015a; Jonas and Izaurralde, 2013).  
 Cells expressing dcp2-N245, an allele encoding a large C-terminal truncation of 
Dcp2, have been shown to lose decapping substrate specificity, i.e., they appear to 
catalyze decapping indiscriminately (He and Jacobson, 2015a). To better understand the 
mechanism of decapping regulation, we generated and characterized RNA-Seq libraries 
from dcp2-N245 cells, as well as from cells expressing two other dcp2 alleles that encode 
single point mutations in the Dcp2 catalytic domain (E153Q and E198Q) in addition to the 
C-terminal deletion. Further, to understand the contributions of different decapping 
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activators, we also generated RNA-Seq libraries from lsm1∆, pat1∆, and dhh1∆ strains. 
Differential expression analyses of these libraries emphasize the regulatory importance 
of the unconserved C-terminal extension of Dcp2 and reveal distinct regulation groups 
determined by the activity of specific decapping activators. In light of the limited 
abundance of Dcp1-Dcp2, different decapping activators are likely to be in competition 
for Dcp1-Dcp2 binding, and tasked with degradation of different mRNAs at various stages 
of the mRNA life cycle. Since the sets of transcripts comprising the activator-specific 
regulatory groups have largely non-overlapping biological functions, this regulatory 
division of labor appears to address specific cellular processes.  
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RESULTS 
 dcp2-N245 cells have a different gene expression profile than dcp2E153Q-
N245 and dcp2E198Q-N245 cells 
 Consistent with the notion that factors interacting with the C-terminal region of 
Dcp2 regulate its substrate specificity, deletion of this large region results in non-specific 
decapping and decay of several transcripts (He and Jacobson, 2015a). To confirm this 
observation and test the consequences of this loss of regulation at a transcriptome-wide 
level, we prepared RNA-Seq libraries from cells harboring a C-terminal truncation of 
DCP2 that only contains the first 245 codons of the gene (dcp2-N245), and from cells 
expressing two other dcp2 truncation alleles that also contain point mutations altering 
important glutamate residues in the active site of Dcp2. E153 of Dcp2 has been shown to 
function as a general base during the hydrolysis reaction and E198 is important for Mg2+ 
coordination within the Nudix domain (Aglietti et al., 2013). Consequently, mutations 
converting these glutamates to glutamines (dcp2E153Q-N245 and dcp2E198Q-N245) 
severely inhibit decapping reactions in vitro (Aglietti et al., 2013).  
 Libraries prepared from all three mutants and wild-type cells showed good read 
count distribution (Fig. 3.1A) and notable consistency between biological replicates, with 
Pearson correlation coefficients ranging from 0.96 to 0.99 (Fig. 3.2 A). Utilizing previously 
described data analysis pipelines for transcript quantitation and assessment of differential 
expression (Celik et al., 2017), we identified 616 upregulated and 1025 downregulated 
transcripts in dcp2-N245 cells, relative to WT cells (Fig. 3.1. B-D). A larger number of 
downregulated transcripts was an expected outcome since the C-terminal domain of 
yeast Dcp2 also contains a negative regulatory element that is responsible for hindering  
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Figure 3.1. Cells harboring catalytically inactive Dcp2 alleles dcp2E153Q-N245 and 
dcp2E198Q-N245 show similar expression profiles which are significantly different 
from that obtained from the indiscriminate dcp2-N245 allele.  
A. RNA-Seq libraries from WT, dcp2-N245, dcp2E153Q-N245, and dcp2E198Q-N245 
strains show comparable read count distributions. Violin and box plots used to visualize the 
average and median read count distributions of each strain from three independent 
biological replicates. B. and C. Transcripts up- and downregulated in dcp2E153Q-N245 
and dcp2E198Q-N245 strains show significant overlap which only partially overlaps with 
the dcp2-N245 strain. Transcripts were identified as differentially expressed by comparing 
read counts to the WT strain. Venn diagrams were used to display the relationships 
between different datasets. Transcripts that are upregulated are presented in (B) and those 
downregulated are presented in (C) D. Differentially expressed transcripts in each single 
deletion strain show a wide range of expression levels. Scatterplots were used to display 
the log2 read count numbers of each transcript in WT, dcp2-N245, dcp2E153Q-N245, and 
dcp2E198Q-N245 strains. A larger number of transcripts showed upregulation in each 
strain. The y=x line is shown in red. Compared to WT cells, the dcp2-N245 strain 
manifested 616 up and 1025 downregulated transcripts, the dcp2E153Q-N245 strain had 
1921 up and 1845 downregulated transcripts, and the dcp2E198Q-N245 strain had 1346 
up and 1428 downregulated transcripts. E. dcp2E153Q-N245 and dcp2E198Q-N245 
strains show virtually identical expression levels for almost all transcripts (leftmost panel). 
Differential expression analysis revealed only 21 transcripts as differentially expressed 
between dcp2E153Q-N245 and dcp2E198Q-N245 backgrounds, whereas there were 1658 
upregulated transcripts and 1690 downregulated transcripts in dcp2E153Q-N245 with 
respect to dcp2-N245 strain, and 1113 upregulated transcripts and 1090 downregulated 
transcripts in dcp2E198Q-N245 strain with respect to the dcp2-N245 strain. 
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Figure 3.2 RNA-Seq libraries generated from WT, lsm1∆, pat1∆, dhh1∆, dcp2-
N245, dcp2E153Q-N245, and dcp2E198Q-N245 strains show good correlation 
between biological replicates 
RNA-Seq libraries show very high Pearson correlation coefficients among biological 
replicates. WT.1, WT.2, and WT.3 are WT controls for lsm1∆, pat1∆, and dhh1∆ 
strains and WT2.1, WT2.2, and WT2.3 are WT controls for the dcp2-N245, 
dcp2E153Q-N245, and dcp2E198Q-N245 strains.  
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Dcp2 activity until it is negated by Dcp2 interaction with one of the decapping activators. 
This is thought to maintain the spatial and temporal regulation of decapping (He and 
Jacobson, 2015a). The loss of this regulation can, therefore, create an indiscriminate and 
hyperactive Dcp2 capable of removing 5’ caps from mRNAs without regard to regulation, 
resulting in the downregulation of many transcripts. Additionally, we observed 1921 
upregulated and 1845 downregulated transcripts in cells expressing the dcp2E153Q-
N245 allele, and 1346 upregulated and 1428 downregulated transcripts in cells 
expressing the dcp2E198Q-N245 allele (Fig. 3.1. B-D). A closer examination of 
upregulated and downregulated transcripts revealed a significant overlap between 
dcp2E153Q-N245 and dcp2E198Q-N245 strains with 1186 and 1362 commonly 
upregulated and downregulated transcripts, respectively (Fig. 3.1 B,C). However, these 
sets only partially overlapped with transcripts that are differentially expressed in the dcp2-
N245 background, with 199 and 550 upregulated and downregulated transcripts, 
respectively, being common to all three backgrounds (Fig. 3.1. B, C). 
 Considering that both the E153 and E198 residues in Dcp2 are located in the Nudix 
domain, the significant overlap between these datasets was not surprising. Nonetheless, 
we wanted to test directly whether dcp2E153Q-N245 cells and dcp2E198Q-N245 cells 
show the same expression patterns, with the different numbers of mRNAs identified due 
to replicate variability. When we applied the same differential expression pipeline to the 
dcp2E153Q-N245 and dcp2E198Q-N245 libraries we identified only 21 transcripts as 
differentially expressed, 4 of which showed higher expression values in dcp2E198Q-N245 
(Fig. 3.1. E leftmost panel). Therefore, we conclude that these two active site mutations 
have the same effect on the transcriptome. Interestingly, a similar comparison with the 
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dcp2-N245 strain showed 1658 upregulated and 1690 downregulated transcripts with 
respect to dcp2E153Q-N245, and 1113 upregulated 1090 downregulated with respect to 
the dcp2E198Q-N245 strain (Fig. 3.1. E middle and right panels), indicating that dcp2-
N245 strains show considerable differences in expression profiles compared to those 
expressing dcp2E153Q-N245 or dcp2E198Q-N245.  
 The Dcp2 C-terminal domain is important for decapping regulation  
 To further assess the concept that the dcp2-N245 allele lacks regulation, but is not 
defective in decapping, we compared expression levels of all transcripts in this strain to 
those we previously published for dcp1∆, dcp2∆, and xrn1∆ strains (Celik et al., 2017) in 
addition to those assessed in dcp2E153Q-N245 and dcp2E198Q-N245 cells. Because 
the dcp1∆, dcp2∆, xrn1∆, and dcp2 C-terminal truncation libraries were prepared at 
different times with different WT controls we chose to improve consistency by comparing 
fold changes of each transcript with respect to the appropriate WT control. As expected, 
results from dcp1∆ and dcp2∆ strains, or from dcp2E153Q-N245 and dcp2E198Q-N245 
strains showed excellent correlation (Pearson correlation coefficient = 0.868 and 0.932, 
respectively) (Fig 3.3).  Consistently, dcp1∆ and dcp2∆ strains were also well correlated 
with those from xrn1∆, dcp2E153Q-N245, and dcp2E198Q-N245 cells (Pearson 
correlation coefficients = 0.748, 0.812, 0.805 for dcp1∆ and 0.734, 0.772, 0.789 for dcp2∆ 
strains, respectively) (Fig. 3.3). In line with the notion that the dcp2-N245 allele lacks 
regulation and targets transcripts at random the changes in transcript expression levels 
showed poor correlations of the dcp2-N245 library with those from dcp1∆, dcp2∆, xrn1∆, 
dcp2E153Q-N245, or dcp2E198Q-N245 strains (Pearson correlation coefficients = 0.371,  
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Figure 3.3. Deletion of the C-terminal extension of Dcp2 results in decapping 
deregulation, but not decapping or decay inactivation 
Scatterplot matrix of log2 fold changes between previously described dcp1∆, dcp2∆, 
and xrn1∆ libraries (Celik et al., 2017) and dcp2-N245, dcp2E153Q-N245, 
dcp2E198Q-N245 libraries compared to their respective WT controls. Pearson 
correlation coefficients of log2 fold changes for each scatterplot comparison are 
shown in red. Log2 fold changes compared to WT in dcp1∆ and dcp2∆ strains, and 
dcp2E153Q-N245 and dcp2E198Q-N245 strains show excellent correlation. They 
are also well correlated with each other and with log2 fold changes in an xrn1∆ strain. 
The dcp2-N245 strain shows poor correlation with all five decapping and decay 
mutants.  
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0.345, 0.379, 0.423 and 0.421 with dcp1∆, dcp2∆, xrn1∆ dcp2E153Q-N245 and 
dcp2E198Q-N245 libraries, respectively) (Fig. 3.3).   
 Lsm1 and Pat1 regulate the same set of transcripts, which partially overlaps 
with the set of regulated by Dhh1 
 Having established the importance of the C-terminal extension of Dcp2 for 
decapping regulation we wanted to focus on individual factors that regulate decapping 
activity and better understand the mechanism of substrate selection by some of the 
factors that associate with the decapping complex. Therefore, we generated RNA-Seq 
libraries, in three biological replicates, from yeast strains harboring single deletions of the 
LSM1, PAT1, or DHH1 genes. Our libraries again showed good read count distribution 
(Fig. 3.4 A) and notable consistency between biological replicates (Fig. 3.2 B). Using the 
same analysis pipeline employed in the experiments of Fig 3.1, we identified 955 
upregulated and 681 downregulated transcripts in lsm1∆ cells, 940 upregulated and 685 
downregulated transcripts in pat1∆ cells, and 1098 upregulated and 788 downregulated 
transcripts in dhh1∆ cells (Fig. 3.4 B-D). A comparison of the lists of transcripts 
differentially expressed in each strain indicated a striking overlap between the results 
obtained in cells with lsm1∆ or pat1∆ backgrounds (864 common upregulated transcripts 
and 583 and common downregulated transcripts). However, these sets of transcripts only 
overlapped partially with the transcripts differentially expressed in the dhh1∆ strain (482 
common upregulated transcripts and 290 common downregulated transcripts in all three 
strains) (Fig. 3.4 B, C).  
 Given the substantial overlap of differentially expressed transcripts between lsm1∆ 
and pat1∆ strains, and the interactions between Pat1 and the Lsm1-7 complex (Wu et al., 
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2014), we tested whether Lsm1 and Pat1 did indeed control the expression of the same 
set of transcripts. Again, utilizing the same differential expression analysis pipeline, 
comparisons between lsm1∆ and pat1∆ cells manifested overall expression levels of all 
transcripts that were remarkably consistent (Fig. 3.4 E, leftmost panel), with only four 
transcripts differentially expressed between the two strains, two of which were accounted 
for by the respective deletions (Fig. 3.1 E, leftmost panel, red dots). We therefore 
concluded that Lsm1 and Pat1 target the same set of transcripts for decapping.  
When we compared the expression levels of transcripts in dhh1∆ and lsm1∆ or 
pat1∆ strains we identified 1385 upregulated transcripts and 1037 downregulated 
transcripts with respect to the lsm1∆ strain, and 1332 upregulated transcripts and 874 
downregulated transcripts with respect to the pat1∆ strain (Fig.1E, last two panels).  
 Transcripts regulated by Lsm1, Pat1, and Dhh1 are different from NMD 
substrates 
 In a recent study (Celik et al., 2017), we identified the substrates of the yeast 
nonsense-mediated mRNA decay (NMD) pathway. Upf1, the main regulator of NMD, has 
been shown to interact with Dcp2 to target NMD substrates for decapping, and one of its 
interaction domains with Dcp2 overlaps with a Pat1-interacting domain (He and 
Jacobson, 2015a). Our identification of discrete Dcp2 domains that interact with 
decapping activators, along with other observations (Jonas and Izaurralde, 2013), led to 
the hypothesis that there can be distinct decapping complexes in the cell with different 
substrate specificities (He and Jacobson, 2015a). To test aspects of this hypothesis, we 
compared the list of transcripts that were differentially expressed in all single upf deletions 
(Celik et al., 2017) to the sets of differentially expressed transcripts described in Fig. 3.1.  
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Figure 3.5. Transcripts regulated by Lsm1, Pat1, and Dhh1 are different from 
NMD substrates 
A. and B. Overlaps of upregulated (A) and downregulated (B) transcripts in dhh1∆, 
lsm1∆ and pat1∆ strains and previously identified NMD substrates (Celik et al., 
2017) using the same analysis pipeline. NMD substrates show minimal overlap with 
differentially expressed transcripts in dhh1∆, lsm1∆, and pat1∆ backgrounds. C. 
First two principal components of principal component using log2 fold changes for 
transcripts compared to WT reveal three distinct groups of expression levels: single 
upf deletions, lsm1∆, pat1∆, and dhh1∆. D. Heatmap of log2 fold changes in upf1∆, 
upf2∆, upf3∆, pat1∆, lsm1∆, and dhh1∆ strains. Red indicates upregulation and 
blue indicates downregulation.  
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We observed minimal overlap between NMD substrates and transcripts upregulated or 
downregulated in lsm1∆, pat1∆, or dhh1∆ strains (Fig. 3.5 A, B). When we compared the 
overall expression levels of all transcripts by principal component analysis or hierarchical 
clustering of log2 fold changes of all transcripts compared to their WT control we observed 
three distinct groups of transcript expression levels (Fig. 3.5 C, D): 1) dhh1∆ alone, 2) 
lsm1∆ and pat1∆, and 3) single upf deletions. These observations support our hypothesis 
that different proteins that interact with the decapping complex regulate the expression of 
different mRNAs (He and Jacobson, 2015a).  
 Validation of bioinformatic analyses 
We validated our bioinformatic analyses by using northern blotting to assess the 
levels of distinct mRNAs that were representative of transcripts identified in the RNA-Seq 
experiments. Among the selected transcripts, six (HXK1, CHA1, RTC3, NQM1, PGM2, 
and TMA2) were upregulated and three (RPP1, TMA19, GPD2) were downregulated in 
RNA-Seq libraries of all three strains, three (CIT2, SDS23, and HOS2) were upregulated 
only in dhh1∆ cells, and three (DIF1, AGA1, and BUR7) were upregulated and one (GTT2) 
was downregulated only in lsm1∆ and pat1∆ backgrounds. We also compared expression 
levels in dcp2E153Q-N245 and dcp2E198Q-N245 strains for all these genes. In all cases, 
we observed similar expression level changes in both the northern and bioinformatics 
analyses (Fig. 3.6). As additional controls, we included upf1∆ and edc3∆ in our northern 
blot analyses.  
 Different decapping complexes are responsible for regulating genes with 
different biological functions 
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Figure 3.6. Validation of bioinformatic analyses by northern blotting 
Northern blotting analyses of A. Transcripts upregulated in all lsm1∆, pat1∆ and 
dhh1∆ strains (HXK1, CHA1, RTC3, NQM1, PGM2, TMA10), B. Transcripts 
downregulated in all lsm1∆, pat1∆ and dhh1∆ strains (RPP1, TMA19, GPD2), C. 
Transcripts upregulated only in dhh1∆ background (CIT2, SDS23, HOS2, 
Transcripts D.  upregulated (DIF1, AGA1) and E. downregulated (GTT2) only in 
lsm1∆ and pat1∆ strains. Total RNA was isolated from the indicated strains and the 
steady-state levels of individual transcripts in these strains were analyzed by 
northern blotting. In each case, a random-primed probe was hybridized to the blot 
and SCR1 served as the loading control. Normalized fold changes after SCR1 
loading control correction compared to WT are presented under each blot.  
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Figure 3.7. Different decapping complexes regulate genes with different biological 
functions 
Gene ontology (GO) term enrichment analysis of biological process, A. cellular component, 
B. function, C. and all three combined D. enriched GO terms manifested a similar pattern 
to transcript expression. Upregulated and downregulated transcripts in lsm1∆ and pat1∆ 
strains showed substantial overlap that only partially overlaps with GO terms enriched in 
dhh1∆ strain.  
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To determine whether the mRNAs regulated by Lsm1, Pat1, or Dhh1 have 
overlapping or non-overlapping biological functions we used the GOrilla web interface 
(Eden et al., 2009) to calculate gene ontology (GO) term enrichment for all the regulation 
groups. Upregulated and downregulated transcripts in pat1∆ and lsm1∆ showed 
significant overlap (Fig. 3.7 A-D), with only partial overlap with transcripts differentially 
expressed in dhh1∆, a pattern closely resembling the differential expression analysis of 
Fig 3.4. These results suggest that transcripts targeted by different decapping complexes 
also have different biological functions in the cell.  
 Upf proteins in competition for Dcp2 with Dhh1, but not with Lsm1 and Pat1 
 We determined whether transcripts upregulated upon single upf deletions were 
down regulated in dhh1∆, lsm1∆, or pat1∆ strains. Because both Dhh1 and Upf1 have 
been implicated in co-translational targeting of their substrates (Hu et al., 2010; Hu et al., 
2009; Radhakrishnan et al., 2016) we first asked whether transcripts downregulated 
exclusively in dhh1∆ cells might contain NMD substrates. We observed a significant 
enrichment for NMD substrates (Fisher’s exact test, p=7.3 x 10-15) among transcripts 
downregulated only in dhh1∆ cells (Fig. 3.8 A). Surprisingly, transcripts downregulated 
only in lsm1∆ and pat1∆ cells were depleted of NMD substrates (Fisher’s exact test, p=6.2 
x 10-6) (Fig. 3.8 C) and transcripts downregulated in all three decapping activator-deficient 
strains showed no enrichment for NMD substrates (Fisher’s exact test p=0.12) (Fig. 3.8 
B). A similar comparison of transcripts exclusively upregulated in dhh1∆ strains with 
transcripts downregulated only in lsm1∆ and pat1∆ cells showed no enrichment (Fisher’s 
exact test p=0.3079) (Fig.3.8 D). Yet, the inverse comparison, i.e. transcripts upregulated 
only in lsm1∆ and pat1∆ strains versus transcripts downregulated only in dhh1∆ cells 
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showed a subtle depletion compared to what would be expected by chance (Fisher’s 
exact test p=0.00117) (Fig. 3.8 E). These results suggest the that different decapping 
complexes can target mRNAs for decay at different stages in the mRNA life cycle and 
decapping complexes that target during similar processes can compete for the Dcp1-
Dcp2 complex.  
  
101 
 
 
  
Figure 3.8. Upf proteins are in competition for Dcp2 with Dhh1, but not with Lsm1 
and Pat1 
A. NMD substrates were represented at a higher ratio than would be expected than by 
chance among transcripts that are downregulated in dhh1∆ B. There was no enrichment 
for NMD substrates among transcripts that are regulated by all three decapping regulators 
C. NMD substrates were depleted among transcripts regulated by Lsm1 and Pat1 only. D. 
Transcripts exclusively upregulated in dhh1∆ strains showed no enrichment among 
downregulated only in lsm1∆ and pat1∆ background E. The inverse comparison from (D) 
revealed a slight depletion. See text for Fisher's exact test p values. 
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DISCUSSION 
 Dcp2 C-terminal extension is crucial for efficient regulation of decapping 
 While the N-terminal domain of Dcp2 is well conserved, the C-terminal extension 
of this protein shows variability in length and sequence among different organisms (Wang 
et al., 2002). This segment of the protein is not essential for catalysis of decapping in vitro 
(LaGrandeur and Parker, 1998; Mugridge et al., 2016; Tharun and Parker, 1999; Valkov 
et al., 2016) and a significant number of biochemical and structural studies have, 
therefore, only focused on the conserved N-terminal domains of Dcp2. Our recent results 
indicate that the Dcp2 C-terminal extension is important for decapping in vivo (He and 
Jacobson, 2015a) and raise questions about experimental approaches that omit this 
domain. We have found that this portion of Dcp2 in yeast is the site of several binding 
domains for decapping activators and contains an inhibitory element that is responsible 
for preventing non-specific mRNA decapping. Because of these sites, deletion of this 
large section results in an overactive and indiscriminate decapping protein that can target 
mRNAs at random (He and Jacobson, 2015a). Using RNA-Seq analyses, we identified 
transcripts that are differentially expressed in cells harboring the dcp2-N245 allele that 
yields a large deletion of the DCP2 C-terminal regulatory domain. As controls, we also 
compared expression levels of dcp2E153Q-N245 and dcp2E198Q-N245 strains (Fig 3.1 
B-D) which, in addition to expressing the same truncation also encode point mutations in 
the active site of Dcp2 that renders these alleles virtually inactive (Aglietti et al., 2013). 
Differential comparisons of the transcripts from these strains revealed that the expression 
profile of dcp2-N245 is drastically different from those of dcp2E153Q-N245 and 
dcp2E198Q-N245 strains. On the other hand, log2 fold changes between the transcript 
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sets of dcp1∆, dcp2∆, xrn1∆, dcp2E153Q-N245, or dcp2E198Q-N245 cells manifested 
high correlation, supporting the idea that these alleles are defective in decapping and/or 
decay (Fig 3.3).  The lack of correlation of expression profiles from cells harboring the 
dcp2-N245 allele with those with dcp1∆, dcp2∆, xrn1∆, dcp2E153Q-N245, or 
dcp2E198Q-N245 mutations provides transcriptome-wide confirmation that the 
decapping enzyme derived from the dcp2-N245 allele lacks substrate specificity, but not 
decapping activity (Fig 3.3).   
 Different decapping activators regulate different subsets of transcripts 
 We identified transcripts that are regulated by the decapping activators Lsm1, 
Pat1, and Dhh1. Consistent with biochemical and structural data, a substantial overlap 
among the transcripts upregulated or downregulated in lsm1∆ or pat1∆ strains (Fig. 3.4 
B, C) provides transcriptome-wide evidence for the functional interdependency of these 
two proteins. In contrast, transcripts regulated by Dhh1 showed only partial overlap with 
Lsm1 and Pat1 decapping substrates (Fig 3.4 B, C), suggesting that this decapping 
regulator has functions that are distinct from those of Lsm1 or Pat1. Previously published 
results suggesting interactions between Dhh1 and Pat1 (Sharif et al., 2013) raise the 
possibility that an Lsm1-7-Pat1-Dhh1 complex (Fig. 3.9) can target a different set of 
mRNAs than those targeted by Lsm1-7-Pat1 or Dhh1 alone. This set of regulatory 
patterns among decapping regulators seems to have a biological significance as well, i.e., 
the enrichment of GO terms mirrors the sets of differentially expressed transcripts and 
does not appear to associate cellular functions and decapping substrates arbitrarily (Fig, 
3.7 A-D).  
104 
 
Based on results from our lab and others (He and Jacobson, 2015a; He et al., 
2014; Jonas and Izaurralde, 2013), we hypothesized that there can be different decapping 
complexes in the cell with different substrate specificities. The targets of these decapping 
complexes are thought to be dependent on the specific set of activators associated with 
Dcp2, allowing regulation of a diverse set of transcripts with a small number of regulatory 
proteins. Recent results from our lab also implied that some of the interactions of 
decapping activators with Dcp2 can be mutually exclusive (He and Jacobson, 2015a). 
The patterns of overlap of transcripts regulated by Dhh1, Lsm1 and Pat1, and Upf1 are 
in line with this model (Fig 3.5). 
 Competition among different decapping complexes 
Our results reinforce the notion that multiple mutually exclusive decapping 
complexes target different transcripts in the cell. If this hypothesis is correct, then 
elimination of one type or related group of decapping activators might result in an increase 
in available Dcp1-Dcp2 for interaction with other decapping regulators. In support of this 
possibility, a subset of NMD substrates was enriched among transcripts that were 
downregulated in dhh1∆ cells (Fig 3.8 A). However, this was not the case for transcripts 
downregulated only in lsm1∆ and pat1∆ strains or in cells harboring all three deletions 
(Fig. 3.8 B, C). This raises the possibility of a more focused hypothesis, i.e., that mRNAs 
targeted for decay co-translationally are in competition for the Dcp1-2 complex. 
Considering the abundances of Upf1, Dhh1, Dcp2, and Dcp1 (6090, 42900, 8530, 2880 
molecules per cell, respectively) (Ghaemmaghami et al., 2003; Huh et al., 2003) 
competition for the Dcp1-Dcp2 complex seems plausible. An alternative explanation is 
that the rate limiting step of the decay mechanism utilized by the Lsm1-7-Pat1 complex 
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is not binding to Dcp2, or substrate selection, but another downstream process, and the 
competition of this complex for Dcp2 will not be reflected by steady-state mRNA levels. 
 A general drawback of measuring steady-state mRNA levels is our inability to 
distinguish direct vs. indirect targets of Lsm1, Pat1, and Dhh1. Because these proteins 
are decay factors it is likely that a majority of upregulated transcripts represent direct 
targets. For the downregulated transcripts, we propose that these represent transcripts 
that are targeted by other decapping regulators due to increased availability of Dcp1-
Dcp2 complexes. Dhh1 and the Lsm1-7-Pat1 complex are not the only decapping 
regulators in the cell; the Upfs, Edc1-3, Scd6, and potentially other proteins, alone or in 
combination, can also target transcripts for decapping (Arribas-Layton et al., 2013). 
Enrichment of NMD substrates among transcripts that are downregulated in dhh1∆ strains 
provides strong support for this hypothesis. The large repertoire of mutually exclusive 
interactions (Jonas and Izaurralde, 2013; Sharif et al., 2013; Tritschler et al., 2009a) is 
also in line with this mode of decapping regulation (Fig 3.9).  
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Figure 3.9 Different decapping complexes have different substrate specificities 
A. NMD substrates are targeted for decay by interactions between Upf1 and Dcp2 (He 
et al., 2013; He and Jacobson, 2015a). B. and C. The substrate specificity of the Lsm1-
7-Pat1 complex is different from that of the Lsm1-7-Pat1-Dhh1 complex. D. Other 
decapping factors can interact with Dhh1 to target additional transcripts for decay. 
Dhh1 can associate with Edc3 or Scd6 and can, in turn, interact with Dcp2 (Fromm et 
al., 2012; He and Jacobson, 2015a; He et al., 2014; Tritschler et al., 2009a). Yeast 
specific decapping regulators Edc1 and Edc3 can bind to Dcp1's EVH1 domain (Borja 
et al., 2011). Unconfirmed interactions are shown as dashed lines, whereas confirmed 
interactions are shown as solid lines.  
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General Discussion 
 Studies done by many groups in recent decades greatly increased our 
understanding of mRNA decay. The factors involved and their network of interactions 
have been revealed for the mRNA quality control pathways NMD, NGD, and NSD, as well 
as those required for general mRNA decay. Structural data have also been reported for 
many complexes and components, and have elucidated the significant conformational 
changes that they undergo. However, a mechanistic understanding of how mRNAs are 
targeted for decay has been limited. My thesis work focused on two different branches of 
mRNA decay (quality control and general decay) and different aspects of substrate 
selection for these pathways. My bioinformatic analyses provided insight into the reason 
why many "normal-looking" transcripts are targeted by NMD (Chapter II) and how a 
diverse pool of transcripts can be targeted for decapping and decay using a limited set of 
regulatory proteins (Chapter III). 
A new class of NMD substrates illustrates the role of NMD in the cell 
 Work presented in Chapter II attempted to accomplish two goals: 1) to determine 
and confirm a high resolution, high confidence list of endogenous NMD substrates in 
yeast and 2) to determine the reason(s) why these substrates are targeted by NMD. NMD 
has widely been regarded as an mRNA quality control pathway. Decades of study 
dedicated to understanding the underpinnings of this pathway relied heavily on reporter 
genes that have been engineered to contain premature termination codons (PTCs). Yet 
these nonsense mutations, however deleterious (Peltz et al., 2013), are rare and do not 
provide a suitable explanation for the universal evolutionary conservation of NMD from 
yeast to plants to mammals. In addition, previous genome wide studies (He et al., 2003; 
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Malabat et al., 2015) identified many endogenous substrates that did not contain 
nonsense codons. In light of these results, it was proposed that the role of NMD was two-
fold; 1) to detect PTC-containing mRNAs and 2) to regulate the expression of subsets of 
genes specific to each model organism and cell type examined (Celik et al., 2015; He and 
Jacobson, 2015b). While factors modulating NMD are well conserved, the subsets of 
genes that are targeted by NMD did not seem to have a functional conservation.  
 Several recent papers made unique observations about endogenous NMD 
substrates that previously escaped detection. Studies conducted by Kawashima and 
colleagues (Kawashima et al., 2014) indicated that pre-mRNA splicing in yeast is less 
precise than previously thought and that there are many “differentially” spliced mRNAs 
that are targeted by NMD. On a similar note, Malabat et al. (Malabat et al., 2015) observed 
that most genes can be expressed in many different minor isoforms. Some of these 
isoforms have transcription start sites that are inside the annotated open reading frame 
and the first ATG the ribosome would encounter is out of frame with respect to the 
annotated start. Clearly, translation of such mRNAs would likely result in premature 
termination and subsequent targeting by NMD.  
 In my thesis work, we observed that the majority of the mRNAs that were 
upregulated upon single deletion of the UPF genes did not contain any distinguishing 
features (e.g., upstream open reading frames, unspliced introns, programmed 
frameshifting, etc.) that could lead to a premature-like termination event. Upon closer 
inspection using ribosome footprint profiling data, we realized that these transcripts 
showed poorer translation fidelity which could only be partially explained by the 
transcription isoforms mentioned above. Therefore, these mRNAs are more prone to 
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mistranslation, possibly due to their lower codon optimalities which have been shown to 
stall ribosomes or slow translation elongation (Brule and Grayhack, 2017; Gamble et al., 
2016; Letzring et al., 2010). 
 These observations lead to the conclusion that the primary role of NMD is not 
addressing the consequences of nonsense mutations, but rather to ensure that proper 
protein production takes place. This hypothesis can also explain the seemingly arbitrary 
selection of biological processes that are endogenously regulated by NMD in each 
organism because the role of NMD is not to regulate gene expression for functional 
purposes but is to monitor protein production. These "probabilistic" NMD substrates not 
only explain why genome wide studies in many different organisms identified normal 
looking mRNAs as substrates, but also provide indirect evidence against the pioneer-
round of NMD activation model (Hosoda et al., 2005; Ishigaki et al., 2001; Lejeune et al., 
2002; Maquat et al., 2010; Sato et al., 2008). If NMD substrates can only be targeted 
during the first round of translation, then the cell would accumulate significant amounts of 
truncated non-functional peptides translated at a completely different frame than the 
annotated gene. This is in direct contrast with the proposed function of NMD, i.e. to protect 
the cell from the effects of potentially dominant-negative effects of truncated or aberrant 
peptides. Being able to detect mistranslation events at any point in time renders NMD a 
much more effective quality control pathway.  
A complex network of activators regulates decapping in the cell 
 Independent of quality control mechanisms such as NMD mRNAs in the cell need 
to be targeted for decay for effective regulation of gene expression. Decapping by the 
Dcp1-Dcp2 complex can occur in vitro (Dunckley and Parker, 1999; Dunckley et al., 
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2001), but decay rates of mRNAs can vary greatly in vivo, implying that decapping and 
decay are subject to regulation. Work done in Chapter III of my thesis suggests a possible 
mechanism for how precise regulation of decapping is achieved in the cell.  
 Almost all biochemical and structural work concerning the decapping complex 
used a C-terminal truncation of the Dcp2 protein (Charenton et al., 2016; Mugridge et al., 
2016; Valkov et al., 2016). While this truncated form of Dcp2 is catalytically active in vitro 
(Dunckley and Parker, 1999), we have recently shown that it lacks important aspects of 
regulation and substrate selection (He and Jacobson, 2015a). Deletion of different 
sections within the Dcp2 C-terminal domain resulted in loss of regulation for at least one 
mRNA (He and Jacobson, 2015a), suggesting that different transcripts are targeted by 
different decapping complexes that associate with this segment of Dcp2. My work in 
Chapter III provides transcriptome-wide evidence for this hypothesis and underscores the 
universal importance of the C-terminal extension of Dcp2. Differential expression analysis 
revealed that Lsm1 and Pat1, Dhh1, and Upf proteins regulate different subsets of 
mRNAs. In addition to targeting different transcripts for decay, the mechanisms with which 
different decapping complexes target their substrates also show divergence. While Dhh1 
and the Upf factors have been shown to target transcripts co-translationally, and the 
mechanism for targeting by the Lsm1-7-Pat1 complex is likely to be different from that of 
the Dhh1 and Upf proteins. Comparisons of upregulated and downregulated transcripts 
also suggested the possibility of competition for Dcp2 between Dhh1 and Upf1, but not 
by the Lsm1-7-Pat1 complex. This observation revealed another aspect of substrate 
selection by different decapping complexes: different factors can confer substrate 
specificity by targeting transcripts at different stages in their life cycle. 
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 Unlike its N-terminal domain, the C-terminal extension of Dcp2 shows poor 
evolutionary conservation (Wang et al., 2002). This observation may reflect the idea that 
factors that interact with this domain are responsible for providing substrate specificity. 
Hypothetically, different organisms and different tissues require different spatial and 
temporal regulation of gene expression, so the ability to maintain effective regulation with 
a limited number of decapping activators may have led to selective pressure on the Dcp2 
C-terminal domain to evolve different interaction networks that are organism specific. 
Some of the unstructured domains in the yeast Dcp2 C-terminal extension show 
similarities for unconserved amino acid sequences in Dcp1 in metazoans. In combination 
with multiple Dcp2 proteins in higher eukaryotes (Grudzien-Nogalska and Kiledjian, 2017) 
regulation of decapping by conserved factors could be achieved by using divergent 
binding sites (Jonas and Izaurralde, 2013).  
Potential issues in bioinformatic analyses 
 Our bioinformatic analyses provided valuable insight into substrate selection 
mechanisms of NMD and general decapping. Due to the design of our experiments, 
however, unambiguous interpretation of some results is difficult. Because we prepared 
our RNA-Seq libraries from strains with single deletions of several genes, at steady-state, 
we cannot definitively differentiate between direct and indirect effects of these genetic 
manipulations. One potential way to resolve this issue is to compare decay rates of the 
transcripts that differed between WT and single deletion strains. Significant changes in 
decay rates or decay mechanisms could certainly reveal direct substrates of each 
decapping factor. Addition of spike-ins for RNA-Seq libraries can also provide additional 
controls for model fitting and differential expression. This additional control would 
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especially improve data analysis in dcp1∆, dcp2∆, dcp2-N245, and xrn1∆ strains, where 
the general mRNA population might be different from WT and therefore have unintended 
consequences during model fitting.  
 Another issue that needs attention is the ribosome profiling analysis pipeline 
(Ingolia et al., 2013). Alignment of ribosome profiling libraries is often performed with 
substantially higher stringencies than in RNA-Seq experiments. For organisms that have 
undergone genome duplication like Saccharomyces cerevisiae, this can result in 
significant underestimation of ribosome occupancies of some mRNAs. Bayesian methods 
for transcript quantitation and Markov-Chain Monte-Carlo methods for confidence interval 
estimation have been successfully applied to RNA-Seq data previously (Li and Dewey, 
2011; Li et al., 2010). These methods can greatly increase read count accuracies for 
transcripts with orthologs in the genome. Application of similar methods or other 
probabilistic approaches to read assignment for ribosome profiling data can alleviate 
some of the inherent problems with existing pipelines. For example, adaptation of 
Bayesian methods proposed by Li et al. (Li et al., 2010) for ribosome profiling by taking 
three nucleotide periodicities or abundances of different orthologs into account can result 
in more accurate estimations of ribosome occupancy.  
Future directions 
 A) Mechanism of NMD activation 
 My work presented in Chapter II has improved our understanding of the role of 
NMD in the cell and provided an explanation for "normal-looking" endogenous NMD 
substrates. However, many aspects of NMD remain unanswered. To gain a better 
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understanding of how Upf proteins are recruited to mRNPs and how these mRNAs are 
targeted for decay requires that some key questions be addressed:  
 1) What is the timing and order of Upf protein association during translation? 
 While translation is required for activation of NMD the specific timing and order of 
Upf factor association has remained a controversial issue. To answer these questions at 
a transcriptome-wide level ribosome footprint profiling libraries from single deletions of 
the UPF genes as well as numerous mutants of these genes can be used to provide 
additional insight. In combination with mutations in translation termination and ribosome 
recycling factors we can obtain a dynamic picture of translation termination and NMD in 
vivo.  
 2) What are the immediate consequences of Upf association? 
 Previous work from our lab has provided indirect evidence suggesting that Upf 
proteins might be responsible for resolving stable premature termination complexes, a 
role reserved for Rli1 during normal termination (Amrani et al., 2004; Ghosh et al., 2010). 
A direct examination of this question using a reconstituted translation system from purified 
components can yield substantial information about the exact role of Upf proteins in the 
cell, such as enzymatic activities, or the roles of each Upf protein or their subsequent 
domains. 
B) Different decapping complexes and their substrates 
 Results presented in Chapter III further confirmed the existence of different 
decapping complexes tasked with targeting different subsets of mRNAs. However, 
transcripts identified as differentially expressed in Chapter III constituted a small fraction 
of all transcripts in the cell, suggesting that there can be additional decapping complexes 
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regulating the expression of many other transcripts, potentially with some redundancy. 
There are two key questions that can greatly improve our understanding of decapping 
and decay regulation: 
 1) What are the components of the different decapping complexes in the cell? 
 Serial pulldown experiments followed by mass spectrometry can reveal the 
contents of different decapping complexes. These experiments can later be 
complemented by systematic two-hybrid experiments to determine individual binding 
sites.  
 2) Which transcripts are directly regulated by these decapping complexes? 
 Determination of transcriptome-wide decay rates from strains that contain 
deletions or disruptions of crucial components of different decapping complexes can 
reveal their direct substrates. Supervised and unsupervised clustering methods and 
thorough statistical analyses can also shed light into decay kinetics of these transcripts. 
In combination with deletions of the XRN1 and SKI2 or SKI7 genes to target 5' to 3' decay 
and 3' to 5' decay pathways we might understand the decay preferences of different 
decapping complexes. 
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APPENDIX A 
TIMING AND SPECIFICITY OF THE POLYSOMAL ASSOCIATION OF Upf1 
 
 
 
 
 
 
 
 
 
 
Contributions to this appendix 
Robin Ganesan performed the affinity purifications of Upf1-bound 80S ribosomes and prepared 
next generation sequencing libraries. 
Illumina sequencing of these libraries, was carried out at Beijing Genomics Institute (BGI).  
Mass spectrometry sample preparation and data analyses were done by Robin Ganesan and 
John Leszyk (Proteomics and Mass Spectrometry Facility, UMass Medical School).  
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INTRODUCTION 
Nonsense-mediated mRNA decay (NMD) is a cytoplasmic surveillance 
mechanism that degrades mRNA transcripts that contain premature termination codons 
(PTCs) (Kervestin and Jacobson, 2012). The mechanism by which nonsense-containing 
mRNAs are recognized and selectively targeted by NMD remains to be determined. 
Overexpression of Upf1 can compensate for mutations in Upf2 and Upf3, but not vice 
versa (Maderazo et al., 2000) and the maximal in vitro activation of the Upf1 ATPase and 
helicase activities requires both Upf2 and Upf3 (Chamieh et al., 2008). These 
observations imply that Upf1 is the key effector of NMD, whereas Upf2 and Upf3 are likely 
to be regulators of Upf1 function. Some current models of NMD activation by premature 
termination postulate that an inappropriate mRNP structure neighboring the PTC allows 
the recruitment of Upf1 to its substrates (Kervestin and Jacobson, 2012). Upf1 co-
localizes with polyribosomes, 80S ribosomes, and 40S ribosomal subunits (Atkin et al., 
1995; Ghosh et al., 2010; Mangus and Jacobson, 1999; Min et al., 2013), and interacts 
with the release factors eRF1 and eRF3 (Czaplinski et al., 1998; Kashima et al., 2006; 
Singh et al., 2008) and a specific ribosomal protein, Rps26 (Min et al., 2013). To map the 
transcriptome positions of ribosomes when they associate with Upf1, we employed the 
selective ribosome profiling approach (Becker et al., 2013). 
RESULTS AND DISCUSSION 
 To assess the timing and specificity of Upf1 association with ribosomes, we 
established methods for selecting Upf1-associated ribosomes. In these experiments, 80S 
ribosomes with or without Upf1 selection were isolated, and libraries were generated from 
the respective ribosome-protected mRNA fragments in two biological replicates. Because 
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pulldown experiments using strains expressing Upf1 at physiological levels manifested 
very low recovery, we opted to utilize Upf1 overexpression strains to increase yield (Fig 
A.1 A). We then determined Upf1 enrichment using mass spectrometry analysis of the 
FLAG-Upf1-associated ribosomes. We observed a ~0.7:1 ratio of ribosomal proteins:Upf1 
by Mascot Distiller quantitation, at least a 7-10-fold enrichment in Upf1-overexpressing 
cells (Fig A.1 B). Upf2 and Upf3 were largely absent from the Upf1-selected 80S 
preparations (data not shown), consistent with previous experiments indicating that Upf2 
and Upf3 are not required for Upf1:80S association (Min et al., 2013).  
 We first wanted to establish the consequences of Upf1 overexpression on the 
yeast transcriptome. We utilized the same differential expression pipeline described in 
Chapter II. Mean FPKM values showed good correlation between WT and overexpression 
RNA-Seq libraries (Fig A.1. C) and we only identified 46 transcripts to be differentially 
expressed, 11 of which were upregulated in Upf1 overexpression strains (Fig A.1. D). 
Within these 46 transcripts 7 were among the NMD substrates described in Chapter II. 
Subsequent chi-square analysis did not reveal any enrichment or depletion for NMD 
substrates (p=0.681). Therefore, we concluded that mRNA expression levels in Upf1 
overexpression strains were mostly comparable to WT cells.  
 We then compared ribosome footprint profiling libraries between WT and Upf1 
overexpression strains. Interestingly, we observed that a significant portion (~50%) of our 
sequencing reads came from ribosomes translating Upf1 (data not shown). This amount 
of enrichment was much larger than what would be expected due to overexpression of 
Upf1. We therefore hypothesized that in addition to obtaining Upf1 bound ribosomes our 
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samples also contain Upf1 nascent chains. We subsequently removed all reads that map 
to the UPF1 ORF before further analysis.  
 Consistent with our previous unpublished results (Min, 2015), we did not observe 
any significant enrichment for NMD substrates in Upf1 pulldown libraries. FPKM 
distributions in pulldown libraries were highly correlated with total ribosomes, but showed 
slightly higher ribosome occupancies in total 80S libraries even when accounted for 
library sizes. This slight shift in ribosome occupancies, however, was comparable 
between NMD substrates and non-substrates (linear regression slope=0.901±0.013 and 
0.914±0.003 for NMD substrates and non-substrates respectively) (Fig A.1. E). Finally, 
we evaluated whether Upf1 associated uniformly within ORFs or whether these 
ribosomes were enriched at the 3' or 5' end of transcripts. Unlike our previous 
observations (Min, 2015), we did not observe an enrichment at the 3' ends of ORFs (Fig. 
A.1. F).  
 Results presented here indicate that Upf1 can interact with ribosomes 
stochastically.  Upf bound ribosomes do not show any significant enrichment for NMD 
substrates or any specific location within the ORF. There is one major caveat that needs 
to be addressed in this study. Upf1 ribosome association might appear non-specific in our 
studies because of excess Upf1 compared to Upf2 or Upf3. Therefore, establishing 
protocols that would allow us to isolate Upf1-bound ribosomes from cells expressing this 
protein at physiological levels in future experiments is crucial for determining the 
dynamics of Upf1 association with ribosomes during translation.  
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Stochastic binding of Upf1 to ribosomes during translation 
A. Western blot of input (I), flowthrough (F), final wash (W), concentrated eluate (Ec) and 
immunoprecipitated (FLAG-Upf1) ribosomes after pelleting through a 10% sucrose cushion (P). B. 
Average of Upf1-normalized Mascot Distiller quantitation values of all detected ribosomal proteins 
normalized against Upf1 from total ribosomes (input) and Upf1-associated ribosomes (pellet) from two 
(FLAG) pulldown experiments. Fold change indicates the change between ribosomal protein:Upf1 
ratios before and after selective pulldown. C-E. Scatterplots of log2(FPKM) values from libraries 
prepared from FLAG-Upf1-containing strains. Reads mapping to Upf1 ORF were omitted from Upf1-
associated ribosome profiling libraries to correct for pulldown of the nascent FLAG-Upf1 peptide. NMD 
substrates identified in Chapter II are in red. (C) mean log2(FPKM) values between RNA-Seq libraries 
prepared from two single-copy (endogenous) and two episomal (overexpressed) Upf1-containing 
strains show good correlation. (D) Transcripts that were differentially expressed between Upf1 
overexpression and WT strains. (E) log2(FPKM) values of all transcripts from different ribosome 
footprint profiling libraries. Orange line and dark blue line represent linear regression fits to NMD 
substrates and non-substrates respectively.  F. Distribution of mean normalized reads over the first 
200 nucleotides after the start codon and the last 200 nucleotides before the stop codon. Reads from 
ribosome profiling libraries were normalized against their respective RNA-Seq libraries per transcript.  
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EFFECTS OF Upf2, eRF1, AND eRF3 ON Upf1 ATPase ACTIVITIES 
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INTRODUCTION 
 Nonsense-mediated mRNA decay (NMD) is a translation quality control pathway 
that recognizes mRNAs whose translation is terminating prematurely (Celik et al., 2015). 
NMD is regulated by three well conserved proteins, Upf1, Upf2, and Upf3 (Cui et al., 1995; 
Gatfield et al., 2003; He et al., 1997; He and Jacobson, 1995; Leeds et al., 1991; Lykke-
Andersen et al., 2000; Nicholson et al., 2012; Nicholson et al., 2010; Perlick et al., 1996; 
Salas-Marco and Bedwell, 2004). Upf1 contains RNA-dependent ATPase and ATP-
dependent RNA helicase activities (Bhattacharya et al., 2000; Czaplinski et al., 1995) that 
have been implicated in mRNP remodeling upon PTC recognition (Ghosh et al., 2010). 
The conserved N-terminal cysteine-histidine rich domain of Upf1 interacts with the C-
terminal domain of Upf2 and, in turn, Upf2 interacts with Upf3 (He et al., 1997). In addition, 
Upf1 can associate with the 40S ribosomal subunit (Min et al., 2013) and eukaryotic 
release factors (eRF1 and eRF3) (Czaplinski et al., 1995; Kashima et al., 2006; Singh et 
al., 2008).  
 Previously published results using recombinant Upf fragments indicated that  Upf2 
and Upf3 can promote (Chamieh et al., 2008) while eRF1 and eRF3 can inhibit (Czaplinski 
et al., 1995) the ATPase and helicase activities of Upf1. However, the enhancement of 
ATP hydrolysis of Upf1 was only observed using a small fragment of Upf2 (Chamieh et 
al., 2008). Similarly, experiments illustrating the effects of release factors on Upf1 were 
performed using recombinant proteins that contained bulky Glutathione S-transferase 
(GST) tags on their N-termini (Czaplinski et al., 1995). We therefore re-assessed the 
influence of Upf2, eRF1, and eRF3 on Upf1. Contrary to previously published results, we 
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observed that Upf2 inhibits, and release factors promote activation of Upf1's ATPase 
activities.  
RESULTS AND DISCUSSION 
 To determine the consequences of Upf2 or eRF binding on Upf1's enzymatic 
activities, we purified full-length FLAG-Upf1 and FLAG-Upf2 directly from Saccharomyces 
cerevisiae and full-length recombinant yeast 6xHis-eRF1 and an N terminally truncated 
(codons 166-685) 6xHis-eRF3 from Escherichia coli. We opted to use a truncated version 
of eRF3 for two reasons: 1) the N-terminal region of eRF3 in yeast contains a prion 
domain that can aggregate at high concentrations, potentially interfering with derivation 
of meaningful results. In addition, this prion domain is responsible for the [PSI+] 
phenotype in yeast, which results in reduced translation termination fidelity (Bradley et 
al., 2003; Cosson et al., 2002; Serio et al., 2001; Serio et al., 1999; Ter-Avanesyan et al., 
1994); 2) Previous results have shown that this N-terminal region is dispensable for NMD, 
translation termination, or growth in vivo (Roque et al., 2015), and would likely have 
minimal effects in our in vitro analyses.  
 Our purification protocols yielded high purity proteins from yeast and bacteria (Fig 
B.1 A). In line with previous observations, purified Upf1 showed RNA-dependent ATPase 
activity (Fig B.1. B, C). Similarly, the GTPase activity of eRF3 was stimulated by addition 
of eRF1 in a dose dependent manner, and eRF1 alone did not have any discernible 
GTPase activity (Fig B.1. D). We then tested the effect of Upf2 on Upf1's ATPase activity. 
Surprisingly, we observed a reduction of ATP hydrolysis when Upf2 was present 
alongside Upf1 (Fig B.1. E). eRF1 or eRF3, on the other hand, manifested the opposite 
result to Upf2, leading to stimulation of ATP hydrolysis by Upf1 (Fig B.1 F). This inhibition 
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or enhancement of ATP hydrolysis was dependent on Upf2 or eRF concentration, namely, 
higher concentrations of Upf2 or eRFs resulted in further inhibition or stimulation of Upf1 
respectively (Fig B.1. G). Our observations are in direct conflict with previously published 
results and underscore the importance of utilizing full-length proteins with small epitope 
tags for in vitro studies whenever possible.  
 Previously it was hypothesized that Upf1 association with eRF1 and eRF3 on a 
prematurely terminating ribosome could result in stabilization of RNA-Upf1 interactions. 
Upon binding to Upf2 and 3 this interaction is resolved with re-activation of Upf1’s 
enzymatic activities (Chamieh et al., 2008). Yet the results presented here suggest the 
opposite mechanism, where a stable Upf complex can bind to a prematurely terminating 
ribosome and dissociation of Upf2 and Upf3 from Upf1 and binding to release factors can 
improve Upf1's enzymatic activities and result in efficient remodeling of the mRNP. Our 
results are also consistent with the observation that yeast Upf2 and Upf3 both interact 
with eRF3 and may compete with eRF1 for eRF3 binding (Wang et al., 2001). These 
interactions can play roles in early steps in recruiting Upf1 to a prematurely terminating 
ribosome.  
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Upf2 inhibits, eRF1 and eRF3 promote Upf1's ATPase activities 
A. Coomassie Brilliant Blue-stained SDS-PAGE gels showing purity of yeast FLAG-Upf1, FLAG-Upf2, 
6xHIS-eRF1, and 6xHIS-eRF3. B-C. Thin layer chromatography showing ATPase activities of Upf1 in the 
presence and absence of poly(U15) RNA. Aliquots were taken at each time point. Reactions were 
quenched with 400mM EDTA and reaction products were separated by thin layer chromatography and 
quantitated using autoradiography. Error bars in (C) indicate standard deviations. D. Similar to (C), but 
with γ-labeled GTP and without poly(U15) RNA. eRF3's GTPase activity was stimulated in the presence 
of eRF1 in a concentration dependent manner. eRF1 alone shows minimal GTPase activity. E. Time 
course experiments indicate that Upf2 diminishes Upf1 enzymatic activity in the presence of RNA; error 
bars show standard deviations. Lines represent linear regression fits for each experimental condition. 
F. Time course ATP hydrolysis assays show that eRF1 and eRF3 stimulate Upf1's ATPase activity in an 
RNA dependent manner. Error bars indicate standard deviations of each time point. Lines represent 
linear regression fits for each experimental condition. G. Concentration dependent inhibition by Upf2 
and stimulation by eRF1 or eRF3. Upf2, eRF3, or eRF1 alone show negligible ATPase activities. 
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APPENDIX C 
ASSOCIATION OF Upf2 AND Upf3 WITH RIBOSOMAL SUBUNITS 
 
 
 
 
 
 
 
 
 
 
Contributions to this appendix 
Feng He prepared HA-Upf2 and HA-Upf3 plasmids.  
Nadia Amrani generated single, double, and triple upf deletion strains.  
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INTRODUCTION 
 Nonsense-mediated mRNA decay (NMD) is a cytoplasmic surveillance 
mechanism responsible for degrading transcripts that contain premature termination 
codons (Celik et al., 2015). Factors that regulate NMD in the yeast Saccharomyces 
cerevisiae include the highly conserved but non-essential proteins, Upf1, Upf2, and Upf3. 
All three Upf proteins associate with polysomes and numerous translation factors (Celik 
et al., 2015). Previous results have indicated that Upf1 can interact with the small 
ribosomal subunit and this interaction dependent on retention of Upf1's ATP hydrolysis 
activities (Min et al., 2013), but not Upf2 or Upf3.  
 To better understand the mechanics of Upf assembly on ribosomes, we 
determined which ribosomal subunits Upf2 and Upf3 interact with and whether this 
interaction is mediated by other Upf proteins. Our results indicate that both Upf2 and Upf3 
can bind to both ribosomal subunits and, while Upf2 binding did not rely on other Upf 
factors, Upf3's association with 40s relies on the presence of either Upf1 or Upf2. These 
results suggest that a complex and dynamic restructuring of prematurely terminating 
mRNPs occurs upon PTC recognition and provide evidence for all three Upf proteins' 
involvement with ribosomes.  
RESULTS AND DISCUSSION 
Upf2 associates with both ribosomal subunits independent of Upf1 or Upf3 
 Previously published results place Upf1 on the small ribosomal subunit (Min et al., 
2013). We therefore wanted to investigate whether this also was the case for Upf2. 
Because there are no available antibodies for yeast Upf2 we transformed upf2∆ cells with 
a plasmid that contained a full length, N-terminal HA tagged Upf2, purified individual 
ribosomal subunits as previously described (Min et al., 2013), and investigated the 
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presence of Upf2 by western blotting. Interestingly, Upf2 associated equally well with both 
ribosomal subunits (Fig C.1 A). When we repeated this experiment in upf1∆, upf3∆, and 
upf1∆ and upf3∆ cells we observed the same phenotype, suggesting that stable 
association of Upf2 did not depend on the presence of either Upf1 or Upf3 (Fig C.1 B-D).  
Upf3 associates with both ribosomal subunits, but its 40S association requires the 
presence of either Upf1 or Upf2 
 We then wanted to determine whether Upf3 showed a similar association pattern 
with ribosomes. Using a similar N-terminal HA-tagged Upf3 protein in upf3∆ strains, in the 
presence of Upf1 and Upf2, Upf3 also associated with both ribosomal subunits (Fig C.1 
E). Single deletions of UPF1 or UPF2 did not alter this association (Fig C.1 F, G 
respectively). However, deletion of both UPF1 and UPF2 resulted in inhibition of Upf3 
association with the 40S (Fig C.1 H).  
 Upf proteins have been implicated in resolving poorly dissociable premature 
termination complexes (Ghosh et al., 2010). Association of Upf2 and Upf3 with both 
ribosomal subunits is consistent with this hypothesis. At PTCs, the Upf complex can 
therefore assume the roles played by ribosome recycling complexes at normal 
termination events (Jackson et al., 2012). Upf3's requirement for either Upf1 or Upf2 also 
suggests a dynamic assembly of these factors upon PTC recognition. However, the stable 
interactions determined in these experiments cannot distinguish whether both ribosomal 
subunits are occupied with Upf2 and/or Upf3 simultaneously. Further experimentation is 
needed to determine the exact location and the order of Upf2 and Upf3 binding to the 
ribosome.  
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Figure C.1. Association of Upf2 and Upf3 with ribosomal subunits.  
Upf2 associates with both ribosomal subunits in WT conditions (A), in the absence of Upf1 
(B), in the absence of Upf3, or in the absence of both Upf1 and Upf3 (D). Upf3 associates 
with both subunits under WT conditions (E), in the absence of Upf2 (F), in the absence of 
Upf1 (G). However, in upf1∆/upf2∆ strains Upf3 only associates with the 60S subunit (H). 
HA-tagged Upf1 or Upf3 were detected with α-HA antibody (upper blots). Western blots 
were also probed with α-Rps6 antibody to determine 40S contamination in 60S samples 
(lower panels). Triple upf deletion strains were used as control (second lane in each panel).  
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CHAPTER II 
Materials and Methods 
Yeast strains 
All strains used in this study are in the W303 background. The wild-type strain (HFY114) 
and its isogenic derivatives harboring deletions of UPF1 (HFY871), UPF2 (HFY116), 
UPF3 (HFY861), DCP1 (HFY1067), or XRN1 (HFY1080) were described previously (He 
et al. 2013), as were isogenic strains harboring deletions of DCP2 (CFY1016), EDC3 
(CFY25), PAT1 (SYY2674), LSM1 (SYY2680), or DHH1 (SYY2686) (He and Jacobson, 
2015a). A strain harboring a deletion of SCD6 (SSY2352) was constructed by gene 
replacement (Guthrie and Fink, 1991) using a DNA fragment harboring the scd6::KanMX6 
null allele. 
Cell growth and RNA isolation 
Cells were all grown in YEPD media at 30C. In each case, cells (15 ml) were grown to 
an OD600 of 0.7 and harvested by centrifugation. Cell pellets were frozen on dry ice and 
then stored at -80C until RNA isolation. The procedures for RNA isolation were as 
previously described (He and Jacobson, 1995).  
RNA-Seq library preparation 
Total RNA was treated with Baseline-Zero DNase (Epicenter) to remove any genomic 
DNA contamination. Five micrograms of DNase-treated total RNA was then depleted of 
rRNA using the Illumina yeast RiboZero Removal Kit and the resulting RNA was used for 
RNA-Seq library preparation. Multiplex strand-specific cDNA libraries were constructed 
133 
 
using the Illumina TruSeq Stranded mRNA LT Sample Prep Kit. Three independent cDNA 
libraries were prepared for each yeast strain analyzed. 
RNA sequencing 
Total RNA cDNA libraries were sequenced on the Illumina HiSeq4000 platform at Beijing 
Genomics Institute. Four independent libraries were pooled into a single lane and single-
end 50-cycle sequencing was carried out for all cDNA libraries. 
Northern analysis 
Procedures for northern blotting were as previously described (He and Jacobson 1995). 
In each case, the blot was hybridized to a random primed probe for a specific transcript, 
with SCR1 serving as a loading control. Transcript-specific signals on northern blots were 
determined with a FUJI BAS-2500 analyzer. Specific PCR fragments from the following 
genes were used as probes for northern blotting analyses presented in Fig. 4: RPL22B, 
entire 321-nt intron; RPS13, entire 539-nt intron; HAC, entire 252-nt intron, HRB1, exon2 
nt 784-1278; NHP6B, CDS nt 1-300; MTR2, CDS nt 1-555; ICR1, nt 2461-3040; IRT1, nt 
811-1340; and TY4, CDS nt 4801-5410. 
Bioinformatic methods 
General computational methods 
All statistical analyses were carried out using the R statistical programming environment, 
versions 3.2.4 and 3.2.5. R packages ggplot2, gplots, plyr, reshape2, and gridExtra were 
used for data pre-processing and visualization, and foreach, doSNOW, and doParallel 
were used for parallel processing. 
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Differential expression analysis 
The R64-2-1 S288C reference genome assembly (sacCer3) (Saccharomyces Genome 
Database Project) was used for sequencing reads mapping and transcriptome 
construction. We generated a yeast transcriptome comprised of 7473 transcripts that 
includes all annotated protein-coding sequences, functional, and non-coding RNAs, and 
the unspliced isoforms of all intron-containing genes. Because of their repetitive nature, 
autonomous replicating sequences and long terminal repeats of transposable elements 
were excluded from the transcriptome. The RSEM program (Li and Dewey 2011) was 
used to map the sequence reads to the transcriptome and to quantify individual transcript 
levels with settings --bowtie-m 30 --no-bam-output --forward-prob 0. The expected read 
counts for individual transcripts from RSEM were considered as the number of reads 
mapped to each transcript and were then imported into the Bioconductor DESeq package 
(Anders and Huber, 2010) for differential expression analysis.  
 The Benjamini-Hochberg procedure was used for multiple testing corrections. To 
account for replicate variability, we used a false discovery threshold of 0.01 (1%) instead 
of an arbitrary fold change cutoff as the criterion for differential expression. We repeated 
the same pipeline for a separate transcriptome that contained CUT, SUT and XUT 
sequences. These sequences were extracted from the yeast genome based on previous 
annotations (Wery et al., 2016). 
Ribosome footprint profiling analysis 
We generated a second transcriptome for ribosome profiling analysis that only included 
mRNAs and unspliced isoforms from verified protein-coding genes. Because there are no 
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formal 5’- and 3’-UTR annotations for most yeast transcripts, we used sequences 300 nt 
upstream of start codons or downstream of stop codons as the 5’- and 3’-UTR sequences. 
For transcripts that have annotated 5’-UTR introns, 300nt immediately upstream of the 
annotated introns were considered as their 5’-UTRs. We used raw data from previously 
published ribosomal profiling experiments (Smith et al., 2014; Young et al., 2015). Raw 
fastq files and sequence reads were trimmed for adapter sequences with cutadapt with 
settings -a CTGTAGGCA -q 10 --trim-n -m 10. After adapter trimming, sequence reads 
were mapped to the transcriptome with bowtie (Langmead et al., 2009) with settings -m 
4 -n 2 -l 15 --suppress 1,6,7,8 --best –strata. Because our transcriptome contains both 
spliced and unspliced isoforms from hundreds of the intron-containing genes, we allowed 
as many as 4 multiple mappings. After bowtie alignment, the riboSeqR (Chung et al., 
2015) was used for initial visualizations and frame calling. All other analyses were carried 
out by R scripts written in-house.  
Ribosome density calculations 
The ratio of profilingcoverage / RNA-Seqcoverage for each transcript along the entirety of either 
intronic or coding regions (Fig. 3A, Fig. 5 A, C), or over 100 bins (percentages) of the 
entire intron or coding regions were calculated using in-house scripts. For this analysis, 
we only used ribosome footprint read lengths that showed a strong preference (>80%) to 
a specific reading frame.  
Calculation of in- and out-of-frame read ratios 
We used only ribosome footprint read lengths that showed a strong preference (>80%) to 
a specific reading frame. Accounting for A-site occupancy, we mapped the reads from 
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each length to our transcriptome and calculated the number of reads mapped to each 
transcript and the number of out-of-frame reads for each transcript for each read length. 
We then pooled the total and out-of-frame reads together and calculated the ratio of out-
of-frame over total reads for each transcript.  
Codon optimality calculations 
We used previously published codon optimality assignments and scores (Pechmann and 
Frydman, 2013) in our analyses. The average codon optimality score for each transcript 
in our ribosome profiling transcriptome was calculated using the Biostrings R package 
and in-house scripts. We took the sum of optimality scores for all codons in a transcript 
and then divided the sum by the total number of codons in the corresponding transcript. 
For discrete time Markov chain analysis, we labelled each codon as optimal (O) or non-
optimal (N) and then calculated the transition probabilities using maximum likelihood 
estimates as an unbiased measure for each transcript using the markovchain R package.  
Statistical tests 
We used chi-square tests with Yates continuity correction to assess different subsets of 
transcripts for either enrichment or depletion of a particular group of transcripts. Because 
the data for ribosome densities, transcript in-frame reads ratios, average codon optimality, 
and codon transition probabilities did not show normal (Gaussian) distributions, we used 
non-parametric two-sample Kolmogrov-Smirnov (K.S.) tests to assess the significance 
between different groups of transcripts. As K.S. tests compare the empirical distributions 
of two population samples, for consistency we used cumulative density plots in Figures 
4-6.  
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The data discussed in this chapter have been deposited in NCBI's Gene Expression 
Omnibus (Edgar et al., 2002) and are accessible through GEO Series accession number 
GSE86428. 
CHAPTER III 
Yeast strains 
All strains used in this study are in the W303 background. The wild-type strain (HFY114) 
and its isogenic derivatives harboring deletions of UPF1, UPF2, UPF3, DCP1, or XRN1 
were described previously (He et al., 2013), as were isogenic strains harboring deletions 
of DCP2, EDC3, PAT1, LSM1, or DHH1 (He and Jacobson, 2015a). Construction of the 
DCP2 alleles dcp2-N245, dcp2E153Q-N245, and dcp2E198Q-N245 was also described 
previously (He and Jacobson, 2015a). 
Cell growth and RNA isolation 
Cells were all grown in YEPD media at 30oC. In each case, cells (15 ml) were grown to 
an OD600 of 0.7 and harvested by centrifugation. Cell pellets were frozen on dry ice and 
then stored at -80oC until RNA isolation. The procedures for RNA isolation were as 
previously described (He and Jacobson 1995).  
RNA-Seq library preparation 
Total RNA was treated with Baseline-Zero DNase (Epicenter) to remove any genomic 
DNA contamination. Five micrograms of DNase-treated total RNA was then depleted of 
rRNA using the Illumina yeast RiboZero Removal Kit and the resulting RNA was used for 
RNA-Seq library preparation. Multiplex strand-specific cDNA libraries were constructed 
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using the Illumina TruSeq Stranded mRNA LT Sample Prep Kit. Three independent cDNA 
libraries were prepared for each yeast strain analyzed. 
RNA sequencing 
Total RNA cDNA libraries were sequenced on the Illumina HiSeq4000 platform at Beijing 
Genomics Institute. Four independent libraries were pooled into a single lane and single-
end 50-cycle sequencing was carried out for all cDNA libraries. 
Northern analysis 
Procedures for northern blotting were as previously described (He and Jacobson 1995). 
In each case, the blot was hybridized to a random primed probe for a specific transcript, 
with SCR1 serving as a loading control. Transcript-specific signals on northern blots were 
determined with a FUJI BAS-2500 analyzer. Specific PCR fragments from the ORFs of 
following genes were used as probes for the northern blotting analyses presented: HXK1 
nt 1-470, CHA1 nt 1-500, RTC3 nt 1-336, NQM1 nt 481-2001, RPGM2 nt 1201-1710, 
TMA10- nt 1-260, RPP1A nt 1-321, TMA19 nt 1-500, GPP2 nt 1-500, CIT2 nt 1-500, 
SDS23 nt 1-500, HOS2 nt 1-500, DIF1 nt 1-400, AGA1 nt 1-500, BUR6 nt 1-429, and 
GTT2 nt 1-500. 
Bioinformatic methods 
General computational methods 
All statistical analyses were carried out using the R statistical programming environment, 
versions 3.3.0 and 3.3.1. R packages ggplot2, gplots, plyr, reshape2, and gridExtra were 
used for data pre-processing and visualization. Biostrings, BiocParallel, snow, and 
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parallel were used for parallel processing. Statistical tests were performed using built-in 
functions in base R distributions.  
Differential expression analysis 
The R64-2-1 S288C reference genome assembly (sacCer3) (Saccharomyces Genome 
Database Project) was used for sequencing reads mapping and transcriptome 
construction. We used Transcriptome 1 described in Chapter 2 for differential expression 
using previously published pipelines (Celik et al. 2017).  
Statistical tests 
Hierarchical clustering was performed using Euclidian distances between libraries and 
transcripts with complete linkage. Non-finite (division by 0), undefined (0 divided by 0) 
values were removed prior to clustering. The heights of the clustering tree branches 
indicate distance between two libraries. We used Fisher's exact test to assess different 
subsets of transcripts for either enrichment or depletion of a particular group of transcripts. 
Gene ontology term enrichment analysis 
We used the GOrilla web interface (Eden et al. 2009) for gene ontology (GO) term 
enrichment analysis for all regulation subgroups. We utilized hypergeometric tests 
between a set of differentially expressed transcripts versus all transcripts. To minimize 
false discovery, we employed a stringent (0.001) p value cutoff for significance.  
 
APPENDIX A 
Cells and treatments 
The pG1-FLAG-Upf1 plasmid (Czaplinski et al., 1995) was transformed into HFY871 (He 
et al., 2013) using previously described methods (Schiestl and Gietz, 1989). Yeast strains 
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were grown on -trp minimal medium until the OD600 reached 0.6-0.8. Cells were 
harvested by vacuum filtration on 80 um filters (Millipore) and resuspended in lysis buffer 
(10 mM Tris, pH 7.4, 100 mM NaCl, 30 mM MgCl2, 1 mM  DTT, 1 mM PMSF, 200 ug/ml 
Heparin), and dripped into liquid N2. Frozen cell pellets were cryogenically ground at 10Hz 
for 15min in a mixer mill (Retsch). Frozen cell powder was thawed on ice and centrifuged 
for 10 min at 5000 rpm.  The supernatant was centrifuged at 13,000 RPM for 10 min at 
4°C. Absorbance at 260 nm was measured and 1 OD260 unit was treated with 0.15 ul of 
RNase I (100 Units/ul of Ambion) for 1 hr at room temperature. 5 ul of Superase-In (20 
U/ul; Ambion AM2694) was added to the RNase I-treated samples and subjected to 
sucrose gradient centrifugation (see below). 
Ribosome isolation 
Lysates were loaded on 34 ml 10-50% sucrose gradients, prepared in low-salt polysome 
buffer (0.5 M Tris acetate pH 7.4, 0.5 M NH4Cl, 0.12 M MgCl2, 10 mM DTT), and 
centrifuged at 28,000 rpm in an SW-28 Ti rotor for 3.15 hr at 4°C. Sucrose gradient 
fractions containing 80S ribosomes were collected and concentrated with 100 kDa 
Amicon filter units (Millipore) to a volume of about 500-1000 ul and saved in aliquots at -
80°C. 
Affinity purification of Upf1-bound ribosomes 
Ribosomes (0.05 pmol) were incubated with 50 µl of magnetic FLAG-M2 beads (Sigma) 
pre-equilibrated with 50mM Tris 7.4, 1M NaCl, 1% NP40, 0.1% SDS, 0.5% NaDOC, and 
50x protease inhibitor cocktail (Roche) for 10 min at 4°C. The magnetic beads were 
washed five times with the same buffer. FLAG-Upf1-associated mRNP complexes were 
eluted with Buffer A supplemented with 10 mM FLAG-Peptide (pH 7.0) by incubating for 
141 
 
10 min at 4°C. The eluted FLAG-Upf1-80S samples were combined and concentrated by 
centrifugation through 100 µl sucrose cushions (50 mM Tris, pH 7.0, 500 mM KOA, 
25 mM Mg[OAc]2, 5 mM β-mercaptoethanol, 1 M sucrose, protease inhibitor, RNase 
inhibitor) at 50,000 rpm for 180 min in a TLS 55 rotor at 4°C. The resulting pellet was 
dissolved in 30 ul of Buffer B (20 mM HEPES, pH 7.0, 100 mM KCl, 1.5 mM MgCl2, 1 mM 
DTT, 0.5 mM spermidine, 0.05% Nikkol, 0.5% protease inhibitor, and 0.1 U/ml RNAsin) 
for 1 hr on a rotating shaker at 4°C. Aliquots of concentrated Upf1-associated ribosomes 
were flash frozen in liquid nitrogen and stored at −80°C. 
Mass spectrometry 
After affinity purification, Upf1-eniriched ribosomes were subjected to 8% SDS-PAGE 
analysis. Gels were silver stained using ProteoSilver Silver Stain Kit (Sigma, PROTSIL1-
1KT) and processed for mass spectrometry (MS) analysis. Destained gel bands were 
denatured, reduced with dithiothreitol, and alkylated with iodoacetamide, and subjected 
to in-gel trypsin digestion. The resulting peptides were subjected to Liquid 
Chromatography/Tandem MS Analysis (LC-MS) on a Thermo LTQ. Protein identification 
was performed with the Mascot Server (version 2.4; Matrix Sciences, Ltd.) using the 
UniProt index of Saccharomyces cerevisiae. Quantitation was performed using Mascot 
Distiller (version 2.4; Matrix Science, Inc.). 
Bioinformatic methods 
Ribosome footprint profiling libraries were analyzed as described in Chapter II methods 
with some modifications. Because Upf1-enriched libraries contained significant amounts 
of reads that mapped to the Upf1 ORF, these were removed before further processing 
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and meta-gene analysis. In addition, due to a lack of discernible three nucleotide 
periodicities we used all sequencing reads between 15-36 nucleotides for our analyses.  
 
APPENDIX B 
Plasmid construction 
For Upf1, a previously described plasmid was used for expression and purification 
(Czaplinski et al., 1995). FLAG-Upf2 was amplified from genomic DNA with primers that 
contain the FLAG tag in frame with the ORF. This DNA fragment was cloned into the 
YEplac112 plasmid that contains the ADH1 promoter and terminator (Roy et al., 2015). 
Full length eRF1, and the eRF3 ORF containing codons 166-685 amplified from genomic 
DNA, were cloned into the PET15b (Novagen) plasmid.  
Protein purification 
Upf1 and Upf2 protein purification was performed as previously described (Bhattacharya 
et al., 2000) with the exception that cells were cryogenically ground as described in 
Appendix A methods. eRF1 and eRF3 plasmids were transformed into BL21 bacterial 
strains and grown under ampicillin selection. Overnight cultures were diluted to OD600 
0.1 and grown until they reached OD600 0.6 in 2L LB-Amp media. Cells were then 
induced with 0.5 mM IPTG and transferred to a 16oC water bath and grown overnight. 
Cells were collected by centrifugation and were suspended in 100mM Hepes pH 7.4, 
100mM NaCl, 10% v/v glycerol. Cell lysis was performed by sonication with 10x 10-
second pulses at 30% power, with 30 second on-ice cooling between pulses. Cell lysates 
were then cleared by centrifugation at 15,000 g for 15 minutes and protein purification 
was performed using 1.5 ml TALON resins (Clonetech) per the manufacturer's 
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recommendations. Elution fractions containing the highest protein concentrations 
determined by Bradford assays were then pooled and dialyzed overnight in 100mM 
Hepes pH 7.4, 100mM NaCl, 10% v/v glycerol. Final protein concentration was measured 
using Bradford assays with BSA as a protein standard. Proteins were aliquoted and 
stored at -80oC. Protein purity was assessed by SDS-PAGE and Coomassie Brilliant Blue 
staining.  
ATP-hydrolysis assays 
A final concentration of 100nM Upf1 protein was combined with 1mM non-radioactive 
ATP, 0.1ul of gamma-labeled ATP (Perkin Elmer), and additional factors or BSA in 1X 
reaction buffer that contained 20mM HEPES, 30mM NaCl, 1mM ZnCl, and 2mM MgCl2, 
and 1uM U15 RNA oligonucleotide to a final volume of 20ul per reaction. The reactions 
were incubated at 30oC and 1ul aliquots were taken at each time point and quenched with 
1ul 400mM EDTA. 1ul of this mixture was than spotted on thin layer chromatography 
plates and air dried for 10 minutes. Plates were developed using 0.15M formic acid and 
0.15M LiCl2, dried using heat lamps, and then exposed to phosphoimager cassettes and 
scanned using a FUJI BAS-2500 analyzer. Signal quantification was performed using 
Multi-gauge software. All experiments were done in triplicate.  
 
APPENDIX C 
Yeast strains used 
All strains are derivatives of S. cerevisiae strain MBS (MATa ade2-1 his3-11,15 leu2-
3,112 trp1-1 ura3-1 can1-100 [rho + ] L-o, M-o) (Iizuka and Sarnow, 1997). NA19 
(upf2::HIS) (Amrani et al., 2004) and NA24 (upf3::HIS) (Ghosh et al., 2010) were 
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previously described. NA35 (upf3::HIS3, upf1::URA2), NA38 (upf1::HIS3, upf2::URA3), 
NA39 (upf3::HIS3, upf2::URA3), and NA44 (upf3::HIS3, upf2::URA3, upf1::LEU2) were 
constructed as previously described (Guthrie and Fink, 1991). The HA-UPF2 plasmid was 
constructed by ligating a 1.2 kb PCR fragment amplified from the region upstream of the 
UPF2 gene to an oligonucleotide containing the 3xHA sequence and a 4kb fragment of 
the UPF2 ORF and downstream sequences to the pRS315 plasmid. Similarly, a 400nt 
PCR fragment amplified from the region upstream of the UPF3 gene was ligated to an 
oligonucleotide containing the 3xHA sequence and a 2kb fragment of the UPF3 ORF and 
downstream sequences to the pRS315 plasmid. Corresponding HA-UPF2 and HA-UPF3 
sequences were then cloned into YCplac112. 
Plasmids and ribosomal subunit purification 
Cells were transformed with HA-UPF2 or HA-UPF3 as previously described (Schiestl and 
Gietz, 1989). Ribosomal subunit purification was performed using the methods described 
by Min et al. (Min et al., 2013). All subunit purifications were done in duplicate from 
independent isolates. Aliquots from subunit purifications were analyzed by western 
blotting. 
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